Quarterly Report (10-q)

00016705412020Q3FALSE--09-3000016705412019-10-012020-06-30xbrli:shares00016705412020-06-30iso4217:USD00016705412020-04-012020-06-3000016705412019-04-012019-06-3000016705412018-10-012019-06-30iso4217:USDxbrli:shares00016705412019-09-3000016705412018-09-3000016705412019-06-30xbrli:pure0001670541adnt:OtherAsiaExcludingChinaMember2020-04-30adnt:segment0001670541us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:OtherNoncurrentAssetsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-06-300001670541us-gaap:OtherNoncurrentAssetsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-09-300001670541us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-06-300001670541us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-09-300001670541us-gaap:OtherCurrentLiabilitiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-06-300001670541us-gaap:OtherCurrentLiabilitiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-09-300001670541us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2020-06-300001670541us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2019-09-300001670541adnt:AdientAerospaceMember2018-10-1100016705412018-10-012018-12-310001670541adnt:AdientAerospaceMember2019-10-250001670541adnt:AdientAerospaceMembersrt:AmericasMember2019-10-252019-10-250001670541adnt:AdientAerospaceMember2019-10-252019-10-250001670541adnt:RECAROMember2019-10-012019-12-310001670541adnt:RECAROMember2018-10-012019-09-300001670541adnt:YanfengMemberadnt:AYMMember2020-01-310001670541adnt:AdientMemberadnt:AYMMember2020-01-310001670541adnt:YanfengMemberadnt:YFASMember2020-01-310001670541adnt:YFASMemberadnt:AdientMember2020-01-310001670541adnt:YanfengMemberadnt:YFAIMember2020-01-310001670541adnt:YFAIMemberadnt:AdientMember2020-01-310001670541adnt:YFAIMember2020-01-310001670541adnt:YFAIMember2020-01-312020-01-3100016705412020-01-312020-01-310001670541adnt:YFAIMemberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputCapRateMemberus-gaap:FairValueInputsLevel3Member2020-04-012020-06-300001670541adnt:YFASMemberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputCapRateMemberus-gaap:FairValueInputsLevel3Member2020-04-012020-06-300001670541adnt:YFAIMember2018-10-012019-09-300001670541adnt:YFASMember2020-06-300001670541adnt:YFASMember2020-01-012020-03-310001670541adnt:AutomotiveFabricsManufacturingMember2020-03-052020-03-05adnt:numberOfEmployees0001670541adnt:AutomotiveFabricsManufacturingMember2020-06-300001670541adnt:AutomotiveFabricsManufacturingMember2018-10-012019-09-300001670541srt:AmericasMember2019-09-300001670541us-gaap:EMEAMember2019-09-300001670541srt:AsiaMember2019-09-300001670541adnt:RECAROMembersrt:AmericasMember2019-10-012020-06-300001670541us-gaap:EMEAMemberadnt:RECAROMember2019-10-012020-06-300001670541adnt:RECAROMembersrt:AsiaMember2019-10-012020-06-300001670541adnt:RECAROMember2019-10-012020-06-300001670541srt:AmericasMember2019-10-012020-06-300001670541us-gaap:EMEAMember2019-10-012020-06-300001670541srt:AsiaMember2019-10-012020-06-300001670541srt:AmericasMember2020-06-300001670541us-gaap:EMEAMember2020-06-300001670541srt:AsiaMember2020-06-300001670541srt:MinimumMemberus-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputCapRateMemberus-gaap:FairValueInputsLevel3Member2019-10-012020-06-300001670541us-gaap:IncomeApproachValuationTechniqueMemberus-gaap:MeasurementInputCapRateMemberus-gaap:FairValueInputsLevel3Membersrt:MaximumMember2019-10-012020-06-300001670541us-gaap:PatentsMember2020-06-300001670541us-gaap:PatentsMember2019-09-300001670541us-gaap:CustomerRelationshipsMember2020-06-300001670541us-gaap:CustomerRelationshipsMember2019-09-300001670541us-gaap:TrademarksMember2020-06-300001670541us-gaap:TrademarksMember2019-09-300001670541us-gaap:OtherIntangibleAssetsMember2020-06-300001670541us-gaap:OtherIntangibleAssetsMember2019-09-300001670541srt:AsiaMember2020-04-012020-06-300001670541us-gaap:OtherIntangibleAssetsMembersrt:AsiaMember2020-04-012020-06-300001670541us-gaap:OtherNoncurrentAssetsMembersrt:AsiaMember2020-04-012020-06-3000016705412020-01-012020-03-3100016705412019-10-010001670541us-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:OtherCurrentLiabilitiesMember2020-06-300001670541us-gaap:OtherNoncurrentLiabilitiesMember2020-06-300001670541us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMemberadnt:TermLoanBLIBORPlus400DueIn2024Member2020-06-300001670541us-gaap:RevolvingCreditFacilityMemberadnt:TermLoanBLIBORPlus400DueIn2024Member2020-06-300001670541us-gaap:RevolvingCreditFacilityMemberadnt:TermLoanBLIBORPlus400DueIn2024Member2019-09-300001670541adnt:NotesDue2026Memberus-gaap:UnsecuredDebtMember2020-06-300001670541adnt:NotesDue2026Memberus-gaap:UnsecuredDebtMember2019-09-300001670541adnt:NotesDue2024Memberus-gaap:UnsecuredDebtMember2020-06-300001670541adnt:NotesDue2024Memberus-gaap:UnsecuredDebtMember2019-09-300001670541adnt:NotesDueIn2026Memberus-gaap:UnsecuredDebtMember2020-06-300001670541adnt:NotesDueIn2026Memberus-gaap:UnsecuredDebtMember2019-09-300001670541adnt:SeniorNotesDue2025900Memberus-gaap:UnsecuredDebtMember2020-06-300001670541adnt:SeniorNotesDue2025900Memberus-gaap:UnsecuredDebtMember2019-09-300001670541adnt:EuropeanInvestmentBankLoanduein2022Memberus-gaap:EurodollarMemberus-gaap:UnsecuredDebtMember2019-10-012020-06-300001670541adnt:EuropeanInvestmentBankLoanduein2022Memberus-gaap:UnsecuredDebtMember2020-06-300001670541adnt:EuropeanInvestmentBankLoanduein2022Memberus-gaap:UnsecuredDebtMember2019-09-300001670541us-gaap:RevolvingCreditFacilityMember2020-06-300001670541us-gaap:RevolvingCreditFacilityMember2019-09-300001670541us-gaap:RevolvingCreditFacilityMember2019-05-060001670541adnt:NorthAmericanSubfacilityMemberus-gaap:RevolvingCreditFacilityMember2019-05-060001670541adnt:EuropeanSubfacilityMemberus-gaap:RevolvingCreditFacilityMember2019-05-0600016705412019-05-062019-05-060001670541us-gaap:EurodollarMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-05-062019-05-060001670541us-gaap:EurodollarMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-05-062019-05-060001670541srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-05-062019-05-060001670541us-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2019-05-062019-05-060001670541us-gaap:LineOfCreditMember2019-05-060001670541us-gaap:LineOfCreditMemberus-gaap:LineOfCreditMember2019-05-060001670541us-gaap:RevolvingCreditFacilityMember2019-10-012020-06-300001670541adnt:TermLoanBLIBORPlus400DueIn2024Memberus-gaap:SecuredDebtMember2019-05-062019-05-060001670541adnt:TermLoanBLIBORPlus400DueIn2024Memberus-gaap:SecuredDebtMember2019-05-060001670541adnt:IncrementalTermLoanMemberus-gaap:UnsecuredDebtMember2019-05-060001670541adnt:TermLoanBLIBORPlus400DueIn2024Membersrt:MaximumMember2019-05-062019-05-060001670541adnt:NotesDueIn2026Memberus-gaap:UnsecuredDebtMember2019-05-06iso4217:EUR0001670541us-gaap:EurodollarMember2020-04-012020-06-300001670541us-gaap:UnsecuredDebtMember2019-10-012020-06-300001670541us-gaap:UnsecuredDebtMember2019-10-012020-03-310001670541srt:ScenarioForecastMemberus-gaap:UnsecuredDebtMember2019-10-012020-09-300001670541adnt:SeniorNotesDue2025900Memberus-gaap:UnsecuredDebtMember2020-04-200001670541adnt:SeniorNotesDue2025900Memberus-gaap:UnsecuredDebtMember2020-04-202020-04-200001670541adnt:NotesDue2024Memberus-gaap:UnsecuredDebtMember2020-04-200001670541us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:LongTermDebtMember2020-06-30adnt:instrument0001670541srt:EuropeMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2020-03-310001670541us-gaap:CrossCurrencyInterestRateContractMember2020-01-012020-03-310001670541srt:EuropeMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2020-06-300001670541country:JPus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2020-06-30iso4217:JPY0001670541us-gaap:InterestRateCapMember2020-06-300001670541us-gaap:ForeignExchangeContractMember2019-12-310001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateCapMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:InterestRateCapMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:InterestRateCapMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:NondesignatedMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMember2019-09-300001670541us-gaap:NondesignatedMember2020-06-300001670541us-gaap:NondesignatedMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2020-06-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2019-09-300001670541us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:LongTermDebtMember2019-09-300001670541us-gaap:NondesignatedMemberus-gaap:LongTermDebtMember2020-06-300001670541us-gaap:NondesignatedMemberus-gaap:LongTermDebtMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-04-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2019-10-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2018-10-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2020-04-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2019-04-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2019-10-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMember2018-10-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-04-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2019-04-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2019-10-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2018-10-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:InterestExpenseMember2020-04-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:InterestExpenseMember2019-04-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:InterestExpenseMember2019-10-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:InterestExpenseMember2018-10-012019-06-300001670541us-gaap:EquitySwapMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-04-012020-06-300001670541us-gaap:EquitySwapMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-04-012019-06-300001670541us-gaap:EquitySwapMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-10-012020-06-300001670541us-gaap:EquitySwapMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2018-10-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2020-04-012020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMember2019-04-012019-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:FairValueInputsLevel1Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2020-06-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:FairValueInputsLevel1Member2020-06-300001670541us-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentLiabilitiesMember2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2020-06-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:FairValueInputsLevel1Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMember2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:FairValueInputsLevel1Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:InterestRateCapMemberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:InterestRateCapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentAssetsMember2019-09-300001670541us-gaap:InterestRateCapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:InterestRateCapMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:FairValueInputsLevel1Member2019-09-300001670541us-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherCurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Memberus-gaap:OtherNoncurrentLiabilitiesMember2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2019-09-300001670541us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2019-09-300001670541srt:EuropeMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2018-09-300001670541country:JPus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2019-09-300001670541us-gaap:CommonStockMember2019-09-300001670541us-gaap:AdditionalPaidInCapitalMember2019-09-300001670541us-gaap:RetainedEarningsMember2019-09-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300001670541us-gaap:ParentMember2019-09-300001670541us-gaap:NoncontrollingInterestMember2019-09-300001670541us-gaap:RetainedEarningsMember2019-10-012020-06-300001670541us-gaap:ParentMember2019-10-012020-06-300001670541us-gaap:NoncontrollingInterestMember2019-10-012020-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-10-012020-06-300001670541us-gaap:AdditionalPaidInCapitalMember2019-10-012020-06-300001670541srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-09-300001670541us-gaap:ParentMembersrt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-09-300001670541srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-09-300001670541us-gaap:CommonStockMember2020-06-300001670541us-gaap:AdditionalPaidInCapitalMember2020-06-300001670541us-gaap:RetainedEarningsMember2020-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001670541us-gaap:ParentMember2020-06-300001670541us-gaap:NoncontrollingInterestMember2020-06-3000016705412019-10-012019-12-310001670541us-gaap:CommonStockMember2020-03-310001670541us-gaap:AdditionalPaidInCapitalMember2020-03-310001670541us-gaap:RetainedEarningsMember2020-03-310001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001670541us-gaap:ParentMember2020-03-310001670541us-gaap:NoncontrollingInterestMember2020-03-3100016705412020-03-310001670541us-gaap:RetainedEarningsMember2020-04-012020-06-300001670541us-gaap:ParentMember2020-04-012020-06-300001670541us-gaap:NoncontrollingInterestMember2020-04-012020-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001670541us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001670541us-gaap:CommonStockMember2018-09-300001670541us-gaap:AdditionalPaidInCapitalMember2018-09-300001670541us-gaap:RetainedEarningsMember2018-09-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-09-300001670541us-gaap:ParentMember2018-09-300001670541us-gaap:NoncontrollingInterestMember2018-09-300001670541us-gaap:RetainedEarningsMember2018-10-012019-06-300001670541us-gaap:ParentMember2018-10-012019-06-300001670541us-gaap:NoncontrollingInterestMember2018-10-012019-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-10-012019-06-300001670541us-gaap:AdditionalPaidInCapitalMember2018-10-012019-06-300001670541us-gaap:CommonStockMember2019-06-300001670541us-gaap:AdditionalPaidInCapitalMember2019-06-300001670541us-gaap:RetainedEarningsMember2019-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001670541us-gaap:ParentMember2019-06-300001670541us-gaap:NoncontrollingInterestMember2019-06-3000016705412018-10-012018-10-310001670541us-gaap:CommonStockMember2019-03-310001670541us-gaap:AdditionalPaidInCapitalMember2019-03-310001670541us-gaap:RetainedEarningsMember2019-03-310001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001670541us-gaap:ParentMember2019-03-310001670541us-gaap:NoncontrollingInterestMember2019-03-3100016705412019-03-310001670541us-gaap:RetainedEarningsMember2019-04-012019-06-300001670541us-gaap:ParentMember2019-04-012019-06-300001670541us-gaap:NoncontrollingInterestMember2019-04-012019-06-300001670541us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300001670541us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001670541us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001670541us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2018-09-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2019-04-012019-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2019-10-012020-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2018-10-012019-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300001670541us-gaap:AccumulatedTranslationAdjustmentMember2019-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-03-310001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-09-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-04-012019-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-10-012020-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-10-012019-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300001670541us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-06-300001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-03-310001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-300001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-09-300001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300001670541us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-06-300001670541adnt:RedeemableNoncontrollingInterestMember2020-03-310001670541adnt:RedeemableNoncontrollingInterestMember2019-03-310001670541adnt:RedeemableNoncontrollingInterestMember2019-09-300001670541adnt:RedeemableNoncontrollingInterestMember2018-09-300001670541adnt:RedeemableNoncontrollingInterestMember2020-04-012020-06-300001670541adnt:RedeemableNoncontrollingInterestMember2019-04-012019-06-300001670541adnt:RedeemableNoncontrollingInterestMember2019-10-012020-06-300001670541adnt:RedeemableNoncontrollingInterestMember2018-10-012019-06-300001670541adnt:RedeemableNoncontrollingInterestMember2020-06-300001670541adnt:RedeemableNoncontrollingInterestMember2019-06-300001670541adnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541srt:AmericasMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541us-gaap:EMEAMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541srt:AsiaMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:A2020RestructuringPlanMember2019-09-300001670541us-gaap:OtherRestructuringMemberadnt:A2020RestructuringPlanMember2019-09-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:A2020RestructuringPlanMember2019-09-300001670541adnt:A2020RestructuringPlanMember2019-09-300001670541us-gaap:EmployeeSeveranceMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541us-gaap:OtherRestructuringMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:A2020RestructuringPlanMember2019-10-012020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:A2020RestructuringPlanMember2020-06-300001670541us-gaap:OtherRestructuringMemberadnt:A2020RestructuringPlanMember2020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:A2020RestructuringPlanMember2020-06-300001670541adnt:A2020RestructuringPlanMember2020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2019Member2019-09-300001670541adnt:RestructuringPlan2019Memberus-gaap:OtherRestructuringMember2019-09-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2019Member2019-09-300001670541adnt:RestructuringPlan2019Member2019-09-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2019Member2019-10-012020-06-300001670541adnt:RestructuringPlan2019Memberus-gaap:OtherRestructuringMember2019-10-012020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2019Member2019-10-012020-06-300001670541adnt:RestructuringPlan2019Member2019-10-012020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2019Member2020-06-300001670541adnt:RestructuringPlan2019Memberus-gaap:OtherRestructuringMember2020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2019Member2020-06-300001670541adnt:RestructuringPlan2019Member2020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2018Member2019-09-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2018Member2019-09-300001670541adnt:RestructuringPlan2018Member2019-09-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2018Member2019-10-012020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2018Member2019-10-012020-06-300001670541adnt:RestructuringPlan2018Member2019-10-012020-06-300001670541us-gaap:EmployeeSeveranceMemberadnt:RestructuringPlan2018Member2020-06-300001670541us-gaap:ForeignCurrencyGainLossMemberadnt:RestructuringPlan2018Member2020-06-300001670541adnt:RestructuringPlan2018Member2020-06-300001670541adnt:RestructuringPlan2017Member2020-06-300001670541adnt:RestructuringPlan2016Member2020-06-300001670541us-gaap:LuxembourgInlandRevenueMemberus-gaap:ForeignCountryMember2019-04-012019-06-300001670541us-gaap:HerMajestysRevenueAndCustomsHMRCMemberus-gaap:ForeignCountryMember2019-04-012019-06-300001670541adnt:PolandTaxAuthorityMemberus-gaap:ForeignCountryMember2019-01-012019-03-310001670541us-gaap:LuxembourgInlandRevenueMemberus-gaap:ForeignCountryMember2019-01-012019-03-3100016705412019-01-012019-03-310001670541adnt:GAASMember2017-10-012018-09-300001670541adnt:GAASMember2018-10-012018-12-310001670541us-gaap:RestructuringChargesMember2019-10-012020-06-300001670541adnt:YFAIMember2019-10-012019-12-310001670541adnt:YFAIMember2020-04-012020-06-300001670541us-gaap:OperatingSegmentsMembersrt:AmericasMember2020-04-012020-06-300001670541us-gaap:OperatingSegmentsMembersrt:AmericasMember2019-04-012019-06-300001670541us-gaap:OperatingSegmentsMembersrt:AmericasMember2019-10-012020-06-300001670541us-gaap:OperatingSegmentsMembersrt:AmericasMember2018-10-012019-06-300001670541us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2020-04-012020-06-300001670541us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2019-04-012019-06-300001670541us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2019-10-012020-06-300001670541us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2018-10-012019-06-300001670541us-gaap:OperatingSegmentsMembersrt:AsiaMember2020-04-012020-06-300001670541us-gaap:OperatingSegmentsMembersrt:AsiaMember2019-04-012019-06-300001670541us-gaap:OperatingSegmentsMembersrt:AsiaMember2019-10-012020-06-300001670541us-gaap:OperatingSegmentsMembersrt:AsiaMember2018-10-012019-06-300001670541us-gaap:IntersegmentEliminationMember2020-04-012020-06-300001670541us-gaap:IntersegmentEliminationMember2019-04-012019-06-300001670541us-gaap:IntersegmentEliminationMember2019-10-012020-06-300001670541us-gaap:IntersegmentEliminationMember2018-10-012019-06-300001670541us-gaap:CorporateNonSegmentMember2020-04-012020-06-300001670541us-gaap:CorporateNonSegmentMember2019-04-012019-06-300001670541us-gaap:CorporateNonSegmentMember2019-10-012020-06-300001670541us-gaap:CorporateNonSegmentMember2018-10-012019-06-300001670541country:CN2020-04-012020-06-300001670541adnt:RECAROMembersrt:AmericasMember2019-10-012019-12-310001670541adnt:YFAIMember2019-10-012020-06-300001670541adnt:FuturisMember2019-04-012019-06-300001670541adnt:FuturisMember2018-10-012019-06-300001670541country:US2020-04-012020-06-300001670541country:US2019-04-012019-06-300001670541country:US2019-10-012020-06-300001670541country:US2018-10-012019-06-300001670541country:MX2020-04-012020-06-300001670541country:MX2019-04-012019-06-300001670541country:MX2019-10-012020-06-300001670541country:MX2018-10-012019-06-300001670541adnt:OtherNonUSMember2020-04-012020-06-300001670541adnt:OtherNonUSMember2019-04-012019-06-300001670541adnt:OtherNonUSMember2019-10-012020-06-300001670541adnt:OtherNonUSMember2018-10-012019-06-300001670541srt:AmericasMemberus-gaap:IntersegmentEliminationMember2020-04-012020-06-300001670541srt:AmericasMemberus-gaap:IntersegmentEliminationMember2019-04-012019-06-300001670541srt:AmericasMemberus-gaap:IntersegmentEliminationMember2019-10-012020-06-300001670541srt:AmericasMemberus-gaap:IntersegmentEliminationMember2018-10-012019-06-300001670541srt:AmericasMember2020-04-012020-06-300001670541srt:AmericasMember2019-04-012019-06-300001670541srt:AmericasMember2019-10-012020-06-300001670541srt:AmericasMember2018-10-012019-06-300001670541country:DE2020-04-012020-06-300001670541country:DE2019-04-012019-06-300001670541country:DE2019-10-012020-06-300001670541country:DE2018-10-012019-06-300001670541country:CZ2020-04-012020-06-300001670541country:CZ2019-04-012019-06-300001670541country:CZ2019-10-012020-06-300001670541country:CZ2018-10-012019-06-300001670541adnt:OtherEMEAExcludingGermanyMember2020-04-012020-06-300001670541adnt:OtherEMEAExcludingGermanyMember2019-04-012019-06-300001670541adnt:OtherEMEAExcludingGermanyMember2019-10-012020-06-300001670541adnt:OtherEMEAExcludingGermanyMember2018-10-012019-06-300001670541us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2020-04-012020-06-300001670541us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2019-04-012019-06-300001670541us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2019-10-012020-06-300001670541us-gaap:EMEAMemberus-gaap:IntersegmentEliminationMember2018-10-012019-06-300001670541us-gaap:EMEAMember2020-04-012020-06-300001670541us-gaap:EMEAMember2019-04-012019-06-300001670541us-gaap:EMEAMember2019-10-012020-06-300001670541us-gaap:EMEAMember2018-10-012019-06-300001670541country:TH2020-04-012020-06-300001670541country:TH2019-04-012019-06-300001670541country:TH2019-10-012020-06-300001670541country:TH2018-10-012019-06-300001670541country:CN2019-04-012019-06-300001670541country:CN2019-10-012020-06-300001670541country:CN2018-10-012019-06-300001670541country:JP2020-04-012020-06-300001670541country:JP2019-04-012019-06-300001670541country:JP2019-10-012020-06-300001670541country:JP2018-10-012019-06-300001670541adnt:OtherAsiaExcludingChinaMember2020-04-012020-06-300001670541adnt:OtherAsiaExcludingChinaMember2019-04-012019-06-300001670541adnt:OtherAsiaExcludingChinaMember2019-10-012020-06-300001670541adnt:OtherAsiaExcludingChinaMember2018-10-012019-06-300001670541srt:AsiaMemberus-gaap:IntersegmentEliminationMember2020-04-012020-06-300001670541srt:AsiaMemberus-gaap:IntersegmentEliminationMember2019-04-012019-06-300001670541srt:AsiaMemberus-gaap:IntersegmentEliminationMember2019-10-012020-06-300001670541srt:AsiaMemberus-gaap:IntersegmentEliminationMember2018-10-012019-06-300001670541srt:AsiaMember2020-04-012020-06-300001670541srt:AsiaMember2019-04-012019-06-300001670541srt:AsiaMember2019-10-012020-06-300001670541srt:AsiaMember2018-10-012019-06-300001670541us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2019-10-012020-06-300001670541us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2018-10-012019-06-30

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


			FORM			10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-37757

Adient plc

(exact name of Registrant as specified in its charter)

Ireland

98-1328821

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

25-28 North Wall Quay, IFSC, Dublin 1, Ireland D01 H104

(Address of principal executive offices)

734-254-5000

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of exchange on which registered

Ordinary Shares, par value $0.001

ADNT

New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer	☑	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

At June 30, 2020, 93,884,381 ordinary shares were outstanding.

Adient plc

Form 10-Q

For the Three Months Ended June 30, 2020

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1.

Unaudited Financial Statements

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Item 4.

Controls and Procedures

PART II - OTHER INFORMATION

Item 1.

Legal Proceedings

Item 1A.

Risk Factors

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Item 3.

Defaults Upon Senior Securities

Item 4.

Mine Safety Disclosures

Item 5.

Other Information

Item 6.

Exhibits

Signatures

Adient plc | Form 10-Q | 2


PART I - FINANCIAL INFORMATION

Item 1.

Unaudited Financial Statements

Adient plc

Consolidated Statements of Income (Loss)

(unaudited)


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions, except per share data)	2020		2019		2020		2019
Net sales	$	1,626	$	4,219	$	9,073	$	12,605
Cost of sales	1,779		4,008		8,726		12,017
Gross profit	(153)		211		347		588
Selling, general and administrative expenses	115		165		407		511
Loss on business divestitures - net	—		—		25		—
Restructuring and impairment costs	49		15		103		159
Equity income (loss)	48		64		(57)		209
Earnings (loss) before interest and income taxes	(269)		95		(245)		127
Net financing charges	58		60		156		135
Other pension expense (income)	(1)		5		(5)		3
Income (loss) before income taxes	(326)		30		(396)		(11)
Income tax provision (benefit)	5		338		75		412
Net income (loss)	(331)		(308)		(471)		(423)
Income (loss) attributable to noncontrolling interests	(6)		13		40		64
Net income (loss) attributable to Adient	$	(325)	$	(321)	$	(511)	$	(487)

Earnings (loss) per share:
Basic	$	(3.46)	$	(3.43)	$	(5.45)	$	(5.21)
Diluted	$	(3.46)	$	(3.43)	$	(5.45)	$	(5.21)

Shares used in computing earnings per share:
Basic	93.9		93.6		93.8		93.5
Diluted	93.9		93.6		93.8		93.5

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 3

Adient plc

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Net income (loss)	$	(331)	$	(308)	$	(471)	$	(423)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	17		(24)		(65)		32
Realized and unrealized gains (losses) on derivatives	24		5		(23)		6

Other comprehensive income (loss)	41		(19)		(88)		38
Total comprehensive income (loss)	(290)		(327)		(559)		(385)
Comprehensive income (loss) attributable to noncontrolling interests	3		14		41		70
Comprehensive income (loss) attributable to Adient	$	(293)	$	(341)	$	(600)	$	(455)

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 4

Adient plc

Consolidated Statements of Financial Position

(unaudited)


(in millions, except share and per share data)	June 30, 2020		September 30, 2019
Assets
Cash and cash equivalents	$	1,032	$	924
Accounts receivable - net	1,161		1,905
Inventories	737		793
Assets held for sale	31		—
Other current assets	498		494
Current assets	3,459		4,116
Property, plant and equipment - net	1,592		1,671
Goodwill	2,039		2,150
Other intangible assets - net	350		405
Investments in partially-owned affiliates	1,090		1,399
Assets held for sale	165		—
Other noncurrent assets	924		601
Total assets	$	9,619	$	10,342
Liabilities and Shareholders' Equity
Short-term debt	$	372	$	22
Current portion of long-term debt	8		8
Accounts payable	1,465		2,709
Accrued compensation and benefits	333		364
Liabilities held for sale	26		—
Restructuring reserve	141		123
Other current liabilities	738		609
Current liabilities	3,083		3,835
Long-term debt	4,147		3,708
Liabilities held for sale	10		—
Pension and postretirement benefits	130		151
Other noncurrent liabilities	635		408
Long-term liabilities	4,922		4,267
Commitments and Contingencies (Note 17)
Redeemable noncontrolling interests	42		51
Preferred shares issued, par value $0.001; 100,000,000 shares authorized, Zero shares issued and outstanding at June 30, 2020	—		—
Ordinary shares issued, par value $0.001; 500,000,000 shares authorized, 93,884,381 shares issued and outstanding at June 30, 2020	—		—
Additional paid-in capital	3,968		3,962
Accumulated deficit	(2,060)		(1,545)
Accumulated other comprehensive income (loss)	(658)		(569)
Shareholders' equity attributable to Adient	1,250		1,848
Noncontrolling interests	322		341
Total shareholders' equity	1,572		2,189
Total liabilities and shareholders' equity	$	9,619	$	10,342

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 5

Adient plc

Consolidated Statements of Cash Flows

(unaudited)


	Nine Months Ended June 30,
(in millions)	2020		2019
Operating Activities
Net income (loss) attributable to Adient	$	(511)	$	(487)
Income attributable to noncontrolling interests	40		64
Net income (loss)	(471)		(423)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation	214		205
Amortization of intangibles	27		31
Pension and postretirement expense (benefit)	2		9
Pension and postretirement contributions, net	(21)		(17)
Equity in earnings of partially-owned affiliates, net of dividends received (includes purchase accounting amortization of $1 and $0, respectively)	85		(11)
Impairment of nonconsolidated partially-owned affiliate	222		—

Deferred income taxes	(13)		304
Non-cash impairment charges	27		66

Loss (gain) on divestitures - net	25		—
Equity-based compensation	8		16
Other	10		18
Changes in assets and liabilities:
Receivables	706		219
Inventories	16		39
Other assets	77		105
Restructuring reserves	(60)		(90)
Accounts payable and accrued liabilities	(1,135)		(185)
Accrued income taxes	9		20
Cash provided (used) by operating activities	(272)		306
Investing Activities
Capital expenditures	(258)		(350)
Sale of property, plant and equipment	5		65
Settlement of cross-currency interest rate swap	10		—

Changes in long-term investments	(37)		3

Other	—		4
Cash provided (used) by investing activities	(280)		(278)
Financing Activities



Increase (decrease) in short-term debt	164		1
Increase (decrease) in long-term debt	600		1,600
Repayment of long-term debt	(6)		(1,202)
Debt financing costs	(10)		(45)




Cash dividends	—		(26)
Dividends paid to noncontrolling interests	(67)		(53)
Formation of consolidated joint venture	—		28
Other	(2)		(3)
Cash provided (used) by financing activities	679		300
Effect of exchange rate changes on cash and cash equivalents	(19)		10
Increase (decrease) in cash and cash equivalents	108		338
Cash and cash equivalents at beginning of period	924		687
Cash and cash equivalents at end of period	$	1,032	$	1,025

The accompanying notes are an integral part of the consolidated financial statements.

Adient plc | Form 10-Q | 6

Adient plc

Notes to Consolidated Financial Statements

(unaudited)

1. Basis of Presentation and Summary of Significant Accounting Policies

Adient is a global leader in the automotive seating supplier industry. Adient has a leading market position in the Americas, Europe and China, and has longstanding relationships with the largest global original equipment manufacturers, or OEMs, in the automotive space. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests, trim covers and fabrics. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world. Adient also participates in the automotive interiors market primarily through its global automotive interiors joint venture in China, Yanfeng Global Automotive Interior Systems Co., Ltd., or YFAI.

For recent developments regarding the planned divestitures of Adient's YFAI investment and the fabrics business, refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements.

Basis of Presentation

The unaudited consolidated financial statements of Adient have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet data as of September 30, 2019 was derived from audited financial statements, but does not include all disclosures required by GAAP. These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair statement of the results of operations, financial position and cash flows of Adient for the interim periods presented. Interim results are not necessarily indicative of full-year results, particularly in fiscal 2020 given the unprecedented situation Adient is facing with the COVID-19 pandemic and the related significant interruption it is having on Adient's operations. Adient's China facilities (including both consolidated and non-consolidated joint ventures) were effectively shut down during the lunar New Year festival (at the end of January) and did not return to operations until the end of March 2020. All of Adient's plants in China are currently operating and all of its customer plants in China have re-opened. Beginning in late March 2020, Adient experienced the shutdown of effectively all of its facilities in the Americas and European regions coinciding with the shutdown of its customer facilities in those regions. Adient also experienced the shutdown of approximately 50% of its plants in Asia (outside China) during late March and early April. During May and June, production started to resume in all regions concurrent with Adient's customers resuming operations. As of June 30, 2020, the majority of Adient's plants have resumed production, although production rates are well below pre-pandemic levels.

Principles of Consolidation

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient's interest exceeds 20% and does not have a controlling interest.

Consolidated VIEs

Based upon the criteria set forth in the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC) 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities (VIEs) for the reporting periods ended June 30, 2020, and September 30, 2019, respectively, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

The carrying amounts and classification of assets (none of which are restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

Adient plc | Form 10-Q | 7


(in millions)	June 30, 2020		September 30, 2019
Current assets	$	201	$	236
Noncurrent assets	80		40
Total assets	$	281	$	276

Current liabilities	$	148	$	235
Noncurrent liabilities	14		—
Total liabilities	$	162	$	235

Earnings Per Share

The following table shows the computation of basic and diluted earnings (loss) per share:


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions, except per share data)	2020		2019		2020		2019
Numerator:
Net income (loss) attributable to Adient	$	(325)	$	(321)	$	(511)	$	(487)

Denominator:
Shares outstanding	93.9		93.6		93.8		93.5
Effect of dilutive securities	—		—		—		—
Diluted shares	93.9		93.6		93.8		93.5

Earnings (loss) per share:
Basic	$	(3.46)	$	(3.43)	$	(5.45)	$	(5.21)
Diluted	$	(3.46)	$	(3.43)	$	(5.45)	$	(5.21)

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted earnings

per share, which is a result of all periods presented being in a loss position.

New Accounting Pronouncements

Standards Adopted During Fiscal 2020

On October 1, 2019, Adient adopted Accounting Standards Codification Topic 842, "Leases" ("ASC 842"). The guidance requires lessees to recognize a lease liability and a right-of-use (ROU) asset for all leases with the exception of short-term leases whose terms are twelve months or less. By applying the optional modified retrospective method, Adient recorded an adjustment as of the adoption date without any retrospective adjustments to comparative financial information. Additionally, Adient elected the package of practical expedients permitted under ASC 842, and accordingly, did not reassess whether existing contracts contain leases, lease classifications, or the treatment of initial direct costs capitalized under the previous standard ("ASC 840"). Adient did not apply the "hindsight" practical expedient upon adoption. Adient did elect to apply the practical expedient to not separate nonlease components from associated lease components. Refer to Note 7, "Leases," of the notes to consolidated financial statements for additional information.

ASU 2018-07, Compensation-Stock Compensation: Improvements to Nonemployee Share-Based Payment Accounting, expands the scope of Topic 718 to include all share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 specifies that Topic 718 applies to all share-based payment transactions in which the grantor acquires goods and services to be used or consumed in its own operations by issuing share-based payment awards. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under

Adient plc | Form 10-Q | 8

ASC 606. The adoption of this guidance on October 1, 2019 did not impact Adient's consolidated financial statements for the nine months ended June 30, 2020.

Standards Effective After Fiscal 2020

Adient has considered the ASUs summarized below, effective after fiscal 2020, none of which is expected to significantly impact the consolidated financial statements:

Standard Adopted

Description

Date Effective

ASU 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments

ASU 2016-13 changes the impairment model for financial assets measured at amortized cost, requiring presentation at the net amount expected to be collected. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts. Available-for-sale debt securities with unrealized losses will now be recorded through an allowance for credit losses.

October 1, 2020

ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement

ASU 2018-13 eliminates, adds, and modifies certain disclosure requirements for fair value measurements. The amendments with respect to changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are to be applied prospectively. All other amendments are to be applied retrospectively to all periods presented.

October 1, 2020

ASU 2018-14, Compensation-Retirement Benefits-Defined Benefit Plans-General: Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans

The amendments in ASU 2018-14 eliminate, add, and modify certain disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. The guidance is to be applied on a retrospective basis to all periods presented.

October 1, 2020

ASU 2018-17, Targeted Improvements to Related Party Guidance for Variable Interest Entities

ASU 2018-17 affects reporting entities that are required to determine whether they should consolidate a legal entity under the guidance within the Variable Interest Entities Subsections of Subtopic 810-10, Consolidation-Overall.

October 1, 2020

ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes

ASU 2019-12 modifies ASC 740, Income Taxes, by simplifying accounting for income taxes. As part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements, the FASB’s amendments may impact both interim and annual reporting periods.

October 1, 2021

2. Revenue Recognition

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has

Adient plc | Form 10-Q | 9

concluded that these activities are not in the scope of ASC 606 and for that reason, there have been no changes to how Adient accounts for reimbursable pre-production costs.

Adient has elected to continue to include shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices. Adient has evaluated the terms of its arrangements and determined that they do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contracts assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet been satisfied and revenue has not been recognized. No significant contract assets or liabilities were identified at September 30, 2019 or at June 30, 2020. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606, paragraph 606-10-50-14 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for disaggregated revenue by geographical market.

3. Acquisitions and Divestitures

Divestitures

Adient Aerospace, LLC ("Adient Aerospace") became operational on October 11, 2018 with Adient's initial ownership position in Adient Aerospace being 50.01%. Initial contributions of $28 million were made during the first quarter of fiscal 2019 by each partner. On October 25, 2019, Adient reached an agreement with Boeing in which Adient's ownership position was reduced to 19.99%, resulting in the deconsolidation of Adient Aerospace on that date, including $37 million of cash. Adient recorded a $4 million loss as a result of the transaction in the Americas segment, including $21 million of allocated goodwill. Adient Aerospace develops, manufactures, and sells a portfolio of seating products to airlines and aircraft leasing companies for installation on Boeing and other OEM commercial airplanes, for both production line-fit and retrofit configurations.

On December 31, 2019, Adient sold the RECARO automotive high performance seating systems business to a group of investors for de minimis proceeds. As a result of the sale, Adient recorded a loss of $21 million during the quarter ending December 31, 2019. For fiscal 2019, the RECARO business recorded $148 million of net sales and insignificant pre-tax income.

On January 31, 2020 (as amended on June 24, 2020), Adient, Yanfeng Automotive Trim Systems Company Ltd. (“Yanfeng”), Adient Yanfeng Seating Mechanisms Co., Ltd. (“AYM”), a joint venture owned, directly or indirectly, by Yanfeng (50%) and Adient (50%), Yanfeng Adient Seating Co., Ltd. (“YFAS”), a joint venture owned, directly or indirectly, by Yanfeng (50.1%) and Adient (49.9%) and YFAI, a joint venture owned, directly or indirectly, by Yanfeng (70%) and Adient (30%), entered into a Master Agreement (the “Agreement”), pursuant to which the parties have agreed, among other things, that:

•Adient will transfer all of the issued and outstanding equity interest in YFAI held, directly or indirectly, by Adient, which represents 30% of YFAI’s total issued and outstanding equity interest, to Yanfeng for $369 million, of which US $309 million will be paid at the closing of the agreed transactions and the remaining US $60 million will be paid on a deferred basis post-closing. With respect to each YFAI fiscal year ending after the closing, starting with the year ending December 31, 2020, Adient will be paid an earnout in an amount equal to 30% percent of YFAI’s distributable earnings for such year until such time as the US $60 million deferred purchase price is fully paid.

•Adient and Yanfeng will amend the YFAS Joint Venture Contract, dated as of October 22, 1997, as amended, and the Articles of Association of YFAS, dated as of October 22, 1997, as amended, in each case in order to extend the term of the YFAS joint venture until December 31, 2038;

•Adient will transfer all patents, trademarks and copyrights, know-how, trade secrets and other intellectual property rights owned by Adient (or certain of its subsidiaries) and used exclusively in the conduct of Adient’s mechanism business as of the date of such transfer (the “Transferred IP”) to AYM for $20 million, and in connection with such transfer, (i) AYM will grant back to Adient a sole license with respect to the Transferred IP on a worldwide and royalty-free basis, (ii) Adient will grant AYM a worldwide and royalty-free license with respect to certain intellectual

Adient plc | Form 10-Q | 10

property rights owned by Adient (or certain of its subsidiaries) and used on a non-exclusive basis in the conduct of Adient’s mechanism business, and (iii) Adient and AYM will license to each other certain improvements to the Transferred IP, as well as certain other intellectual property rights developed or acquired by Adient, AYM or certain of their respective subsidiaries and relating to the mechanism business; and

•Adient and Yanfeng will amend the AYM Equity Joint Venture Contract, dated as of September 9, 2013, as amended, and the Articles of Association of AYM, dated as of September 9, 2013, as amended to, among other things, (i) make certain governance changes such that Yanfeng may control and consolidate the results of AYM for financial reporting and accounting purposes, and (ii) expand AYM’s business and customer scope such that it may carry out its seating mechanism business anywhere in and outside of the People’s Republic of China, in each case, on the terms and subject to the conditions set forth in the Agreement and the relevant definitive agreements to be entered into in connection therewith.

The transactions agreed on January 31, 2020, as amended on June 24, 2020, are cross-conditioned on each other and closing is subject to regulatory approvals, including the State Administration for Market Regulation in the People’s Republic of China, and other customary closing conditions. The transactions are expected to be completed by the end of Adient's fiscal 2020. Proceeds from the transactions are expected to be used by Adient for general corporate purposes or to potentially pay down a portion of Adient’s debt subject to the ongoing impacts of the COVID-19 pandemic. The terms of the Master Agreement as described above are consistent with non-binding terms reached in December 2019.

As a result of the January 31, 2020 agreement, as amended on June 24, 2020, described above, Adient concluded that indicators of other-than-temporary impairment were present related to the investment in YFAI as of December 31, 2019 and June 30, 2020. Upon entering into a formal agreement to sell the YFAI investment, Adient determined that other-than-temporary impairment did exist and recorded a $216 million non-cash impairment of Adient's YFAI investment during the quarter ended December 31, 2019. As a result of the June 24, 2020 modifications to the agreement described above, Adient recorded $6 million of additional non-cash impairment of Adient's YFAI investment during the quarter ended June 30, 2020. The impairments were determined based on combining the fair value of consideration received for all transactions contemplated within the Master Agreement, including an estimated fair value of the YFAS joint venture extension, and allocating the total consideration received to the individual transactions based on relative fair values. Adient estimated the fair value of the individual transactions using both an income approach and market approach. The inputs utilized in the fair value analyses of the transactions are classified as level 3 inputs within the fair value hierarchy as defined in ASC 820, "Fair Value Measurement" and primarily consisted of expected future operating margins and cash flows of YFAI, estimated production volumes, estimated dividend payments from YFAS over the extension period, estimated terminal values of YFAS, market comparables, weighted-average costs of capital (YFAI - 15.0%, YFAS - 10.5%), and noncontrolling interest discounts. As a result of the pending divestiture of the YFAI investment and the corresponding impairment, Adient ceased recognizing equity income from YFAI subsequent to December 31, 2019 (YFAI equity income was $40 million in fiscal 2019). In addition, upon the closing of the transaction, an intangible asset of $92 million will be recorded associated with the YFAS joint venture extension to be amortized over the 18-year term of the extension.

On March 5, 2020, Adient entered into an agreement to sell its automotive fabrics manufacturing business including the lamination business to Sage Automotive Interiors for $175 million. Proceeds from the transaction are expected to be used by Adient for general corporate purposes or to potentially pay down a portion of Adient's debt subject to the ongoing impacts of the COVID-19 pandemic. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to be completed by the end of Adient's fiscal 2020. The sale transaction includes 11 facilities globally with the majority located in EMEA, with approximately 1,300 employees. The assets and liabilities belonging to the business, including $83 million of allocated goodwill, have been classified as assets and liabilities held for sale, respectively, as of June 30, 2020. For fiscal 2019, the fabrics manufacturing business recorded $227 million of net sales and $8 million of pre-tax income.

All of the divestiture transactions described above align with Adient's strategy of focusing on its core, high-volume seating business.

Adient plc | Form 10-Q | 11

4. Inventories

Inventories consisted of the following:


(in millions)	June 30, 2020		September 30, 2019
Raw materials and supplies	$	569	$	609
Work-in-process	24		32
Finished goods	144		152
Inventories	$	737	$	793

5. Goodwill and Other Intangible Assets

The changes in the carrying amount of goodwill are as follows:


(in millions)	Americas		EMEA		Asia		Total
Balance at September 30, 2019	$	638	$	429	$	1,083	$	2,150
Business divestitures	(21)		(83)		—		(104)

Currency translation and other	(10)		4		(1)		(7)
Balance at June 30, 2020	$	607	$	350	$	1,082	$	2,039

Due to the COVID-19 pandemic and the significant interruption it has caused to Adient’s operations, Adient tested goodwill and intangible assets for impairment for each of its reporting units for the quarter ended March 31, 2020 using a fair value method based on management's judgments and assumptions regarding future cash flows. The fair value of a reporting unit refers to the price that would be received to sell the unit as a whole in an orderly transaction between market participants at the measurement date. Adient estimated the fair value of each of its reporting units using an income approach, which utilized Level 3 unobservable inputs. These calculations contain uncertainties as they require management to make assumptions about market comparables, future cash flows, and the appropriate discount rates (based on weighted average cost of capital ranging from 15.0% to 17.5% as of March 31, 2020) to reflect the risk inherent in the future cash flows and to derive a reasonable enterprise value and related premium. The estimated future cash flows reflect management's latest assumptions of the financial projections as of March 31, 2020 based on current and anticipated competitive landscape, including estimates of revenue based on production volumes over the foreseeable future and long-term growth rates, and operating margins based on historical trends and future cost containment activities. The financial projections also considered the impact that COVID-19 is having on Adient’s current and future operations as well as the impact to new vehicle sales in future years. As a result of the test, there was no goodwill impairment recorded during the quarter ended March 31, 2020. A change in any of these estimates and assumptions, especially as it relates to the extent of the COVID-19 pandemic’s impacts on vehicle production volumes within the automotive industry as well as the demand for new vehicle sales once the current operational interruptions are over, could produce significantly lower fair values of Adient's reporting units, which could have a material impact on its results of operations. Based on the resumption of production during the third quarter of fiscal 2020 as well as future year forecasts approximating previous expectations, no goodwill impairment triggering events were identified as of June 30, 2020.

Adient plc | Form 10-Q | 12

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:


	June 30, 2020										September 30, 2019
(in millions)	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Intangible assets
Patented technology	$	28	$	(19)	$	9	$	27	$	(17)	$	10
Customer relationships	490		(170)		320		494		(129)		365
Trademarks	43		(29)		14		51		(32)		19
Miscellaneous	18		(11)		7		21		(10)		11
Total intangible assets	$	579	$	(229)	$	350	$	593	$	(188)	$	405

During the three months ended June 30, 2020, a pre-tax non-cash impairment of $27 million was recorded in the Asia segment related to customer relationship intangible assets of $24 million and $3 million of other long-lived assets within the Futuris China business due to an overall decline in forecasted operations within that business. The impairment was calculated based on a fair value method using discounted cash flows that involves the use of management's judgments and estimates related to forecasted revenue, operating costs and discount rates.

Amortization of other intangible assets for the nine months ended June 30, 2020 and 2019 was $27 million and $31 million, respectively.

Refer to Note 15, "Segment Information," of the notes to consolidated financial statements for more information on Adient's reportable segments.

6. Product Warranties

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.

The changes in Adient's total product warranty liability are as follows:


	Nine Months Ended June 30,
(in millions)	2020		2019
Balance at beginning of period	$	22	$	11
Accruals for warranties issued during the period	9		9
Changes in accruals related to pre-existing warranties (including changes in estimates)	(1)		6

Settlements made (in cash or in kind) during the period	(5)		(4)

Balance at end of period	$	25	$	22

In the second quarter of fiscal 2019, Adient recorded $7 million of warranty expense to correct a prior period error related to incurred but not yet reported warranty expense. Adient has concluded that this adjustment was not material to previously reported financial statements.

Adient plc | Form 10-Q | 13

7. Leases

Adient adopted Accounting Standards Codification Topic 842, Leases (ASC 842), and all the related amendments using the modified retrospective method, without adjusting the comparative financial information, on October 1, 2019. As a result, financial information for reporting periods beginning on or after October 1, 2019 are presented in accordance with ASC 842. Upon adoption, Adient recognized right-of-use (ROU) assets of $380 million and corresponding lease liabilities of $384 million on October 1, 2019. The adoption date ROU asset balance was adjusted by $4 million, reflecting impairment of ROU assets for certain real estate leases (within the North America and Europe asset groups) of which the Company determined the carrying value of the initial operating lease ROU asset exceeded its fair value. The adjustment was recorded as an increase to the opening accumulated deficits. The adoption of ASC 842 did not have any significant impact on the consolidated statement of income or cash flows.

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles. The Company has elected not to record leases with an initial term of 12 months or less on its consolidated statement of financial position.

A lease liability and corresponding right-of-use asset are recognized based on the present value of lease payments. To determine the present value of lease payments, the Company uses its incremental borrowing rate as of lease commencement. The incremental borrowing rate (IBR) is defined as the rate Adient would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Adient primarily derives its IBR from its debt portfolio, adjusted for collateralization, lease term and jurisdictional factors. Adient's finance leases are not significant and are not included in the following disclosures.

The components of lease costs for the three months and nine months ended June 30, 2020 were as follows:


(in millions)	Three Months Ended June 30, 2020		Nine Months Ended June 30, 2020
Operating lease cost	$	30	$	94
Short-term lease cost	6		18

Total lease cost	$	36	$	112

Operating lease right-of-use assets and lease liabilities included in the consolidated statement of financial position were as follows:


(in millions)		June 30, 2020
Operating lease right-of-use assets	Other noncurrent assets	$	324

Operating lease liabilities - current	Other current liabilities	$	88
Operating lease liabilities - noncurrent	Other noncurrent liabilities	238
		$	326

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of June 30, 2020 were as follows:

Adient plc | Form 10-Q | 14


	Operating leases
Fiscal years (in millions)	June 30, 2020
2020 (excluding the nine months ended June 30, 2020)	$	28
2021	98
2022	71
2023	56
2024	41
Thereafter	91
Total lease payments	385
Less: imputed interest	(59)
Present value of lease liabilities	$	326

Future minimum operating lease payments accounted for under ASC 840 at September 30, 2019 were as follows:


	Operating leases
Fiscal years (in millions)	September 30, 2019
2020	$	119
2021	91
2022	64
2023	51
2024	40
After 2024	94
Total minimum lease payments	$	459

Supplemental cash flow information related to leases was as follows:


(in millions)	Nine Months Ended June 30, 2020
Right-of-use assets obtained in exchange for lease obligations:
Operating leases (non-cash activity)	$	34

Operating cash flows:
Cash paid for amounts included in the measurement of lease liabilities	$	95

The weighted average remaining lease term for Adient's operating leases as of June 30, 2020 was 5 years. The weighted average discount rate for Adient's operating leases as of June 30, 2020 was 5.7%.

Adient plc | Form 10-Q | 15

8. Debt and Financing Arrangements

Debt consisted of the following:


(in millions)	June 30, 2020		September 30, 2019
Long-term debt:
Term Loan B - LIBOR plus 4.00% due in 2024	$	792	$	798
4.875% Notes due in 2026	900		900
3.50% Notes due in 2024	1,122		1,094
7.00% Notes due in 2026	800		800
9.00% Notes due in 2025	600		—
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022	—		180


Less: debt issuance costs	(59)		(56)
Gross long-term debt	4,155		3,716
Less: current portion	8		8
Net long-term debt	$	4,147	$	3,708

Short-term debt:
ABL Credit Facility	$	179	$	—
European Investment Bank Loan - EURIBOR plus 1.58% due in 2022	185		—
Other bank borrowings	8		22
Total short-term debt	$	372	$	22

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate plus an applicable margin of 1.50% to 2.00%. Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. As of June 30, 2020, Adient had drawn down $179 million on the ABL Credit Facility and had availability under this facility of $155 million (net of $107 million of letters of credit). During July 2020, Adient voluntarily repaid the outstanding balance of the ABL revolving credit balance.

In addition, Adient US and Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintain a term loan credit agreement (the “Term Loan B Agreement”) providing for a 5-year $800 million senior secured term loan facility that was fully drawn at closing. The Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity on May 6, 2024. Interest on the Term Loan B Agreement accrues at the Eurodollar rate plus an applicable margin equal to 4.25% (with one 0.25% step down based on achievement of a specific secured net leverage level starting with the fiscal quarter ending December 31, 2019). The Term Loan B Agreement also permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions.

Adient plc | Form 10-Q | 16

Adient US also maintains an indenture relating to the issuance of $800 million aggregate principal amount of Senior First Lien Notes. These notes mature on May 15, 2026 and bear interest at a rate of 7.00% per annum. Interest on these notes is payable semi-annually in arrears on November 15 and May 15 of each year, commencing on November 15, 2019.

The ABL Credit Facility, Term Loan B Agreement and the Senior First Lien Notes due 2026 contain covenants that are usual and customary for facilities and transactions of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient’s capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient’s and its restricted subsidiaries’ assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains $0.9 billion aggregate principal amount of 4.875% USD-denominated unsecured notes due 2026 and €1.0 billion aggregate principal amount of 3.50% unsecured notes due 2024. Adient Germany Ltd. & Co. KG, a wholly owned subsidiary of Adient, maintains €165 million in an unsecured term loan from the European Investment Bank ("EIB") due in 2022. The loan bears interest at the 6-month EURIBOR rate plus 158 basis points. Adient amended the EIB loan agreement as of June 30, 2020 to increase the net leverage ratio to 6.75x from 5.25x at June 30, 2020. Future net leverage ratio requirements (5.25x at September 30, 2020 with step downs starting in fiscal 2021) were not adjusted. Adient is forecasting that it will not be in compliance with this net leverage ratio during the next 12 months and will be required to either obtain another amendment or waiver or will pay down the EIB loan. Accordingly, Adient has classified this debt as short term debt at June 30, 2020.

On April 20, 2020, Adient US offered $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if Adient Global Holdings Ltd (“AGH”) has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes will be paid on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above.

Net Financing Charges

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Interest expense, net of capitalized interest costs	$	56	$	46	$	152	$	119
Banking fees and debt issuance cost amortization	5		18		13		25
Interest income	(2)		(4)		(9)		(8)
Net foreign exchange	(1)		—		—		(1)
Net financing charges	$	58	$	60	$	156	$	135

9. Derivative Instruments and Hedging Activities

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient plc | Form 10-Q | 17

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of accumulated other comprehensive income (AOCI) and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. As a result of the COVID-19 impacts and the resulting interruptions to Adient's operations, a loss of $2 million related to ineffective hedges was reclassified to the consolidated statement of income for the three months ended March 31, 2020. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at June 30, 2020 and September 30, 2019, respectively.

As of June 30, 2020, the €1.0 billion aggregate principal amount of 3.50% euro-denominated unsecured notes due 2024 was designated as a net investment hedge to selectively hedge portions of Adient's net investment in Europe. The currency effects of Adient's euro-denominated bonds are reflected in AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment in Europe.

Adient entered into cross-currency interest rate swaps during fiscal 2018 to selectively hedge portions of its net investment in Europe. The currency effects of the cross-currency interest rate swaps are reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient's net investment in Europe. During the three months ended March 31, 2020, Adient settled the one remaining cross-currency interest rate swap for $10 million in proceeds, resulting in no outstanding Euro denominated cross-currency interest rate swaps as of June 30, 2020.

Adient entered into a cross-currency interest rate swap during fiscal 2019 to selectively hedge portions of its net investment in Japan. The currency effects of the cross-currency interest rate swap is reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient's net investment in Japan. As of June 30, 2020, Adient had one cross-currency interest rate swap outstanding totaling approximately ¥11 billion designated as a net investment hedge in Adient's net investment in Japan.

Adient purchased interest rate caps during fiscal 2019 to selectively limit the impact of USD LIBOR increases on its interest payments related to Adient's Term Loan B Agreement. The interest rate caps are designated as cash flow hedges under ASC 815. As of June 30, 2020, Adient had two outstanding interest rate caps with total notional amount of approximately $200 million.

Adient entered into a ¥950 million foreign exchange forward contract during the first quarter of fiscal 2020 to selectively hedge portions of its net investment in China. The currency effects of the forward contract are reflected in the AOCI account within shareholders' equity attributable to Adient, where they offset gains and losses recorded on Adient’s net investment in China. The forward contract matured in June 2020.

Adient plc | Form 10-Q | 18

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:


	Derivatives and Hedging Activities Designated as Hedging Instruments under ASC 815						Derivatives and Hedging Activities Not Designated as Hedging Instruments under ASC 815
(in millions)	June 30, 2020		September 30, 2019		June 30, 2020		September 30, 2019
Other current assets
Foreign currency exchange derivatives	$	2	$	5	$	2	$	3
Cross-currency interest rate swaps	—		12		—		—
Other noncurrent assets
Foreign currency exchange derivatives	1		—		—		1
Interest rate cap	—		1		—		—
Cross-currency interest rate swaps	1		1		—		—
Total assets	$	4	$	19	$	2	$	4

Other current liabilities
Foreign currency exchange derivatives	$	40	$	12	$	—	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	6		3		—		—

Long-term debt
Foreign currency denominated debt	1,122		1,094		—		—
Total liabilities	$	1,168	$	1,109	$	—	$	—

Adient enters into International Swaps and Derivatives Associations (ISDA) master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of June 30, 2020 and September 30, 2019, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:


	Assets						Liabilities
(in millions)	June 30, 2020		September 30, 2019		June 30, 2020		September 30, 2019
Gross amount recognized	$	6	$	23	$	1,168	$	1,109
Gross amount eligible for offsetting	(3)		(9)		(3)		(9)
Net amount	$	3	$	14	$	1,165	$	1,100

Adient plc | Form 10-Q | 19

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income related to cash flow hedges:


(in millions)	Three Months Ended June 30,									Nine Months Ended June 30,
			2020			2019			2020			2019
Foreign currency exchange derivatives	$	18		$	6		$	(39)		$	5

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income:


(in millions)		Three Months Ended June 30,						Nine Months Ended June 30,
				2020		2019		2020		2019
Foreign currency exchange derivatives	Cost of sales	$	(15)	$	(1)	$	(9)	$	(3)

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):


(in millions)		Three Months Ended June 30,						Nine Months Ended June 30,
				2020		2019		2020		2019
Foreign currency exchange derivatives	Cost of sales	$	—	$	(1)	$	(1)	$	(2)
Foreign currency exchange derivatives	Net financing charges	3		(1)		6		—
Equity swap	Selling, general and administrative	—		—		—		(13)
Total		$	3	$	(2)	$	5	$	(15)

The effective portion of pretax gains (losses) recorded in currency translation adjustment (CTA) within other comprehensive income (loss) related to net investment hedges was $(25) million and $(20) million for the three months ended June 30, 2020 and 2019, respectively. For the three months ended June 30, 2020 and 2019, respectively, no gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges. There was no ineffectiveness on cash flow hedges during the three months ended June 30, 2020 and 2019,

10. Fair Value Measurements

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

Adient plc | Form 10-Q | 20

Recurring Fair Value Measurements

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:


	Fair Value Measurements Using:
(in millions)	Total as of June 30, 2020		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	4	$	—	$	4	$	—

Other noncurrent assets
Foreign currency exchange derivatives	1		—		1		—
Cross-currency interest rate swaps	1		—		1		—


Total assets	$	6	$	—	$	6	$	—
Other current liabilities
Foreign currency exchange derivatives	$	40	$	—	$	40	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	6		—		6		—



Total liabilities	$	46	$	—	$	46	$	—


	Fair Value Measurements Using:
(in millions)	Total as of September 30, 2019		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Foreign currency exchange derivatives	$	8	$	—	$	8	$	—
Cross-currency interest rate swaps	12		—		12		—
Other noncurrent assets
Foreign currency exchange derivatives	1		—		1		—
Cross-currency interest rate swaps	1		—		1		—
Interest rate cap	1		—		1		—
Total assets	$	23	$	—	$	23	$	—
Other current liabilities
Foreign currency exchange derivatives	$	12	$	—	$	12	$	—
Other noncurrent liabilities
Foreign currency exchange derivatives	3		—		3		—
Total liabilities	$	15	$	—	$	15	$	—

Valuation Methods

Foreign currency exchange derivatives Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income.

Adient plc | Form 10-Q | 21

Cross-currency interest rate swaps Adient selectively uses cross-currency interest rate swaps to hedge portions of its net investment in Europe. During fiscal 2018, Adient entered into two floating to floating cross-currency interest rate swaps totaling approximately €160 million designated as net investment hedges in Adient's net investment in Europe. During fiscal 2019, Adient entered into one floating to floating cross-currency interest rate swap totaling ¥11 billion designated as a net investment hedge in Adient's net investment in Japan. During fiscal 2019 and the first nine months of fiscal 2020, Adient settled both Euro denominated cross-currency interest rate swaps. As of June 30, 2020, Adient had one ¥11 billion cross-currency interest rate swap outstanding.

Interest rate caps Adient selectively uses interest rate caps to limit the impact of floating rate interest payment increases on its Term Loan B Agreement. The interest rate caps are designated as cash flow hedges under ASC 815. As of June 30, 2020, Adient had two interest rate caps outstanding totaling approximately $200 million.

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $3.9 billion and $3.4 billion at June 30, 2020 and September 30, 2019, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

11. Equity and Noncontrolling Interests

For the nine months ended June 30, 2020:


(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2019	$	—	$	3,962	$	(1,545)	$	(569)	$	1,848	$	341	$	2,189
Net income (loss)	—		—		(511)		—		(511)		26		(485)
Foreign currency translation adjustments	—		—		—		(66)		(66)		1		(65)
Realized and unrealized gains (losses) on derivatives	—		—		—		(23)		(23)		—		(23)

Dividends attributable to noncontrolling interests	—		—		—		—		—		(28)		(28)
Change in noncontrolling interest share	—		—		—		—		—		(18)		(18)
Share based compensation	—		6		—		—		6		—		6
Adjustments from adoption of a new standard	—		—		(4)		—		(4)		—		(4)
Other	—		—		—		—		—		—		—
Balance at June 30, 2020	$	—	$	3,968	$	(2,060)	$	(658)	$	1,250	$	322	$	1,572

The deconsolidation of Adient Aerospace in the quarter ended December 31, 2019 resulted in a $18 million change in noncontrolling interest.

Adient plc | Form 10-Q | 22

For the three months ended June 30, 2020:


(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2020	$	—	$	3,966	$	(1,735)	$	(690)	$	1,541	$	342	$	1,883
Net income (loss)	—		—		(325)		—		(325)		(6)		(331)
Foreign currency translation adjustments	—		—		—		8		8		2		10
Realized and unrealized gains (losses) on derivatives	—		—		—		24		24		—		24


Dividends attributable to noncontrolling interests	—		—		—		—		—		(16)		(16)


Share based compensation	—		1		—		—		1		—		1
Other	—		1		—		—		1		—		1
Balance at June 30, 2020	$	—	$	3,968	$	(2,060)	$	(658)	$	1,250	$	322	$	1,572

For the nine months ended June 30, 2019:


(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at September 30, 2018	$	—	$	3,951	$	(1,028)	$	(531)	$	2,392	$	325	$	2,717
Net income (loss)	—		—		(487)		—		(487)		40		(447)
Foreign currency translation adjustments	—		—		—		26		26		4		30
Realized and unrealized gains (losses) on derivatives	—		—		—		6		6		—		6
Dividends declared ($0.275 per share)	—		—		(26)		—		(26)		—		(26)
Dividends attributable to noncontrolling interests	—		—		—		—		—		(35)		(35)

Share based compensation	—		10		—		—		10		—		10
Formation of consolidated joint venture	—		—		—		—		—		28		28
Other	—		(2)		—		—		(2)		—		(2)
Balance at June 30, 2019	$	—	$	3,959	$	(1,541)	$	(499)	$	1,919	$	362	$	2,281

During October 2018, Adient declared a dividend of $0.275 per ordinary share, which was paid in November 2018.

For the three months ended June 30, 2019:


(in millions)	Ordinary Shares		Additional Paid-in Capital		Retained Earnings (Accumulated Deficit)		Accumulated Other Comprehensive Income (Loss)		Shareholders' Equity Attributable to Adient		Shareholders' Equity Attributable to Noncontrolling Interests		Total Equity
Balance at March 31, 2019	$	—	$	3,956	$	(1,220)	$	(479)	$	2,257	$	373	$	2,630
Net income (loss)	—		—		(321)		—		(321)		7		(314)
Foreign currency translation adjustments	—		—		—		(25)		(25)		(1)		(26)
Realized and unrealized gains (losses) on derivatives	—		—		—		5		5		—		5


Dividends attributable to noncontrolling interests	—		—		—		—		—		(17)		(17)

Share based compensation			2		—		—		2		—		2
Other	—		1		—		—		1		—		1
Balance at June 30, 2019	$	—	$	3,959	$	(1,541)	$	(499)	$	1,919	$	362	$	2,281

Adient plc | Form 10-Q | 23

The following table presents changes in AOCI attributable to Adient:


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Foreign currency translation adjustments
Balance at beginning of period	$	(632)	$	(472)	$	(558)	$	(523)
Aggregate adjustment for the period, net of tax	8		(25)		(66)		26
Balance at end of period	$	(624)	$	(497)	$	(624)	$	(497)
Realized and unrealized gains (losses) on derivatives
Balance at beginning of period	$	(55)	$	(6)	$	(8)	$	(7)
Current period changes in fair value, net of tax	12		5		(30)		6
Reclassification to income, net of tax	12		—		7		—
Balance at end of period	$	(31)	$	(1)	$	(31)	$	(1)
Pension and postretirement plans
Balance at beginning of period	$	(3)	$	(1)	$	(3)	$	(1)

Balance at end of period	$	(3)	$	(1)	$	(3)	$	(1)
Accumulated other comprehensive income (loss), end of period	$	(658)	$	(499)	$	(658)	$	(499)

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Beginning balance	$	35	$	37	$	51	$	47
Net income	—		6		14		24
Foreign currency translation adjustments	7		2		—		2
Dividends	—		—		(23)		(28)

Ending balance	$	42	$	45	$	42	$	45

12. Retirement Plans

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:



	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Service cost	$	2	$	2	$	6	$	6
Interest cost	2		3		8		9
Expected return on plan assets	(4)		(4)		(14)		(12)
Net actuarial and settlement (gain) loss	1		6		1		6
Net periodic benefit cost	$	1	$	7	$	1	$	9

Adient plc | Form 10-Q | 24

The interest cost and expected return on plan assets components of net periodic benefit cost are included in other pension expense (income) in the consolidated statements of income (loss).

13. Restructuring and Impairment Costs

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary.

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $86 million. Of the restructuring costs recorded, $15 million relates to the Americas segment, $62 million relates to the EMEA segment and $9 million relates to the Asia segment. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions. The restructuring actions are expected to be substantially completed by fiscal 2022. Also recorded in fiscal 2020 is $10 million of prior year underspend.

The following table summarizes the changes in Adient's 2020 Plan reserve:


(in millions)	Employee Severance and Termination Benefits		Other		Currency Translation		Total
Original Reserve	$	83	$	3	$	—	$	86
Utilized—cash	(22)		—		—		(22)
Noncash adjustment—other	—		(3)		3		—
Balance at June 30, 2020	$	61	$	—	$	3	$	64

The following table summarizes the changes in Adient's 2019 Plan reserve:


(in millions)	Employee Severance and Termination Benefits		Other		Currency Translation		Total
Balance at September 30, 2019	$	69	$	3	$	(2)	$	70
Utilized—cash	(25)		—		—		(25)

Noncash adjustment—underspend	(6)		—		—		(6)
Balance at June 30, 2020	$	38	$	3	$	(2)	$	39

The following table summarizes the changes in Adient's 2018 Plan reserve:


(in millions)	Employee Severance and Termination Benefits		Currency Translation		Total
Balance at September 30, 2019	$	24	$	(4)	$	20
Utilized—cash	(8)		—		(8)

Noncash adjustment—underspend	(3)		1		(2)
Balance at June 30, 2020	$	13	$	(3)	$	10

There were no material changes during fiscal 2020 to the 2017 and 2016 Plan's reserve balances at June 30, 2020 of $3 million, and $24 million, respectively.

Adient plc | Form 10-Q | 25

Adient's fiscal 2020, 2019, 2018, 2017 and 2016 restructuring plans included workforce reductions of approximately 12,000 employees. Restructuring charges associated with employee severance and termination benefits are paid over the severance period granted to each employee or on a lump sum basis in accordance with individual severance agreements. As of June 30, 2020, approximately 7,800 of the employees have been separated from Adient pursuant to the restructuring plans. In addition, the restructuring plans included twenty plant closures. As of June 30, 2020, seventeen of the twenty plants have been closed.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry, particularly related to the COVID-19 pandemic, could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

Refer to Note 5, "Goodwill and Other Intangible Assets," of the notes to consolidated financial statements for additional information related to impairment of intangible assets during the three months ended June 30, 2020.

14. Income Taxes

Adient has historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pretax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. Due to the uncertainty related to the impact of the COVID-19 pandemic on the Company’s operations at a jurisdictional level that is required to estimate an annual effective tax rate for the full fiscal year, Adient used a discrete effective tax rate method to calculate an income tax provision for the nine-month period ended June 30, 2020. For the three and nine months ended June 30, 2020, Adient’s income tax expense was $5 million equating to an effective tax rate of (2)% and $75 million equating to an effective tax rate of (19)%, respectively. For the three months ended June 30, 2020, income tax expense was recognized rather than a tax benefit that would have been recognized by applying the statutory rate of 12.5% against pre-tax losses, primarily due to the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax benefit related to an impairment charge recorded in the Asia segment related to customer relationship intangible asset. For the nine months ended June 30, 2020, income tax expense was recognized rather than a tax benefit that would have been recognized by applying the statutory rate of 12.5% against pre-tax losses, primarily due to the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances and foreign currency remeasurement of Mexican peso denominated deferred tax assets, partially offset by a tax benefit related to the impairment of Adient’s YFAI investment and a tax benefit related to an impairment charge recorded in the Asia segment related to customer relationship intangible assets. For the three and nine months ended June 30, 2019, Adient’s income tax expense was $338 million equating to an effective tax rate of 1,127% and $412 million equating to an effective rate of (3,745)%, respectively. The three and nine month income tax expense was higher than the statutory rate impact of 12.5% primarily due to the recognition of valuation allowances in Luxembourg, Poland, and the United Kingdom and the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances.

Valuation Allowances

As a result of the Company's third quarter fiscal 2020 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined that no changes to valuation allowances were required.

As a result of Adient's third quarter fiscal 2019 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence (including the external debt refinancing, the related incremental net financing costs, and the restructuring of the internal financing which occurred in the third quarter of fiscal 2019), Adient determined that it was more likely than not that deferred tax assets in Luxembourg and the United Kingdom would not be realized and recorded income tax expense of $229 million and $25 million, respectively, to establish valuation allowances. In addition, as a result of the valuation allowances, Adient recorded an income tax expense of $48 million to adjust the year-to-date tax expense to reflect the higher estimated annual effective tax rate.

As a result of Adient's second quarter fiscal 2019 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence (including the long-lived asset impairment recorded in the second quarter of fiscal 2019), Adient determined that it was more likely than not that deferred tax assets within

Adient plc | Form 10-Q | 26

certain Poland entities would not be realized and recorded a net income tax expense of $43 million in the second quarter of fiscal 2019 to establish a valuation allowance.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Uncertain Tax Positions

At June 30, 2020, Adient had gross tax effected unrecognized tax benefits of $404 million. If recognized, $118 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at June 30, 2020 was approximately $14 million (net of tax benefit). The interest and penalties accrued for the three and nine months ended June 30, 2020 was $1 million and $4 million, respectively. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

Impacts of Tax Legislation and Change in Statutory Tax Rates

On March 27, 2020, the House passed the Coronavirus Aid, Relief, and Economic Security Act (The CARES Act), also known as the Third COVID-19 Supplemental Relief bill, and the president signed the legislation into law. Adient does not expect the provisions of the legislation to have a significant impact on the effective tax rate or the income tax payable and deferred income tax positions of the Company.

During the third quarter of fiscal 2019, Luxembourg enacted legislation reducing the nominal corporate tax rate to 17.0% from 18.0%. For Adient, this reduced its aggregate income tax rate to 24.9% from 26.0% and applies retroactively to the fiscal 2019 tax year. As a result of the law change, Adient recorded income tax expense of $10 million related to the write down of deferred tax assets.

During the first quarter of fiscal 2019, Guangzhou Adient Automotive Seating Co., Ltd. was approved for High and New Tech Enterprise status for the three-year period of 2018 to 2020, thereby reducing their tax rate from 25% to 15%. As a result, a $7 million income tax benefit was recorded on the reduction of deferred tax liabilities and a reduction of 2018 calendar year income taxes.

Other tax legislation was adopted during the quarter in various jurisdictions, which did not have a material impact on Adient’s consolidated financial statements.

Other Tax Matters

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $86 million. Refer to Note 13, “Restructuring and Impairment Costs,” of the notes to the consolidated financial statements for additional information. The tax benefit associated with the restructuring charge was $3 million.

During the third quarter of fiscal 2020, an impairment charge of $27 million was recorded in the Asia segment related to customer relationship intangible assets. Refer to Note 5, “Goodwill and Other Intangible Assets,” of the notes to the consolidated financial statements for additional information. The tax benefit associated with the impairment charge was $5 million.

During the first quarter of fiscal 2020, Adient recognized a pre-tax non-cash impairment of $216 million in equity income related to Adient's YFAI investment. Refer to Note 3, “Acquisitions and Divestitures,” of the notes to the consolidated financial statements for additional information. The tax benefit associated with the impairment charge was $4 million. An additional impairment of $6 million was recorded in the third quarter of fiscal 2020 related to this investment, with no additional tax benefit being recorded.

During the second quarter of fiscal 2019, Adient recognized a pre-tax impairment charge on long-lived assets of $66 million. Refer to Note 13 "Restructuring and Impairment Costs," of the notes to the consolidated financial statements for additional

Adient plc | Form 10-Q | 27

information. The tax benefit associated with the impairment charge was $2 million, which was negatively impacted by geographic mix and Adient’s current tax position in these jurisdictions.

15. Segment Information

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Net Sales
Americas	$	593	$	2,010	$	4,093	$	5,860
EMEA	698		1,752		3,750		5,170
Asia	346		530		1,362		1,779
Eliminations	(11)		(73)		(132)		(204)
Total net sales	$	1,626	$	4,219	$	9,073	$	12,605


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Adjusted EBITDA
Americas	$	(83)	$	69	$	117	$	146
EMEA	(94)		53		17		114
Asia	71		110		311		387
Corporate-related costs ⁽¹⁾	(16)		(27)		(59)		(75)
Restructuring and impairment costs ⁽²⁾	(49)		(15)		(103)		(159)
Purchase accounting amortization ⁽³⁾	(9)		(11)		(30)		(32)
Restructuring related charges⁽⁴⁾	(5)		(5)		(17)		(27)
Loss on business divestitures - net ⁽⁵⁾	—		—		(25)		—
Impairment of nonconsolidated partially-owned affiliate ⁽⁶⁾	(6)		—		(222)		—
Depreciation	(67)		(68)		(214)		(205)
Stock based compensation	(7)		(8)		(8)		(16)
Other items ⁽⁷⁾	(4)		(3)		(12)		(6)
Earnings (loss) before interest and income taxes	(269)		95		(245)		127
Net financing charges	(58)		(60)		(156)		(135)
Other pension income (expense)	1		(5)		5		(3)
Income (loss) before income taxes	$	(326)	$	30	$	(396)	$	(11)

Adient plc | Form 10-Q | 28

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects qualified restructuring charges for costs that are directly attributable to restructuring activities and meet the definition of restructuring under ASC 420 and non-recurring impairment charges. Restructuring charges during the three and nine months ended June 30, 2020 primarily consist of workforce reductions and a $27 million pre-tax non-cash impairment charge related to long-lived assets in China. Restructuring charges during the three and nine months ended June 30, 2019 primarily consist of workforce reductions; the nine months ended June 30, 2019 also includes a $66 million non-cash impairment charge related to long-lived assets in the seat structure and mechanism operations.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420.

(5) Reflects losses on business divestitures, of which $4 million is related to the deconsolidation of Adient Aerospace, and $21 million is the result of the sale of the RECARO automotive high performance seating systems.

(6) Reflects the non-cash impairment of Adient's YFAI investment as described in Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements.

(7) The three months ended June 30, 2020 reflects $4 million of transaction costs and the nine months ended June 30, 2020 reflects $11 million of transaction costs and $1 million of tax adjustments at YFAI. The three months ended June 30, 2019 reflects $1 million of Futuris integration costs and $2 million of transaction costs. The nine months ended June 30, 2019 reflects $4 million of Futuris integration costs and $2 million of transaction costs.

Adient plc | Form 10-Q | 29

Geographic Information

Revenue by geographic area is as follows:


Net Sales
	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Americas
United States	$	519	$	1,649	$	3,469	$	4,894
Mexico	192		700		1,379		2,013
Other Americas	17		106		236		330
Regional elimination	(135)		(445)		(991)		(1,377)
	593		2,010		4,093		5,860
EMEA
Germany	150		375		765		1,106
Czech Republic	166		385		806		1,123
Other EMEA	571		1,500		3,217		4,412
Regional elimination	(189)		(508)		(1,038)		(1,471)
	698		1,752		3,750		5,170
Asia
Thailand	44		139		307		468
China	130		126		372		410
Japan	34		104		262		389
Other Asia	140		163		425		516
Regional elimination	(2)		(2)		(4)		(4)
	346		530		1,362		1,779

Inter-segment elimination	(11)		(73)		(132)		(204)

Total	$	1,626	$	4,219	$	9,073	$	12,605

Adient plc | Form 10-Q | 30

16. Nonconsolidated Partially-Owned Affiliates

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the "Investments in partially-owned affiliates" line in the consolidated statements of financial position as of June 30, 2020 and September 30, 2019. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the "Equity income (loss)" line in the consolidated statements of income (loss) for the nine months ended June 30, 2020 and 2019, respectively.

Adient maintains total investments in partially-owned affiliates of $1.1 billion and $1.4 billion at June 30, 2020 and September 30, 2019, respectively. Operating information for nonconsolidated partially-owned affiliates is as follows:


	Nine Months Ended June 30,
(in millions)	2020		2019
Income statement data:
Net sales	$	7,319	$	11,736
Gross profit	$	829	$	1,358
Net income	$	387	$	494
Net income attributable to the entity	$	381	$	480

Refer to Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements for recent developments regarding certain of Adient's investments in partially-owned affiliates.

17. Commitments and Contingencies

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, casualty environmental, safety and health, intellectual property, employment, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $11 million and $12 million at June 30, 2020 and September 30, 2019, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, and the often quite lengthy periods over which eventual remediation may occur. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.

Adient plc | Form 10-Q | 31

18. Related Party Transactions

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the net sales to and purchases from related parties included in the consolidated statements of income:


		Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)		2020		2019		2020		2019
Net sales to related parties	Net sales	$	60	$	97	$	255	$	277
Purchases from related parties	Cost of sales	138		205		447		555

The following table sets forth the amount of accounts receivable due from and payable to related parties in the consolidated statements of financial position:


(in millions)		June 30, 2020		September 30, 2019
Accounts receivable due from related parties	Accounts receivable	$	61	$	73
Accounts payable due to related parties	Accounts payable	87		137

Average receivable and payable balances with related parties remained consistent with the period end balances shown above.

Adient plc | Form 10-Q | 32

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This section and other parts of this Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," or similar terms. Forward-looking statements are not guarantees of future performance and Adient's actual results may differ significantly from the results discussed in the forward-looking statements. Adient cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Adient’s control, that could cause Adient’s actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: the continued financial and operational impacts of and uncertainties relating to the COVID-19 pandemic on Adient and its customers, suppliers, joint venture partners and other parties, the ability of Adient to close its sale of its fabrics business, including receipt of necessary regulatory approvals, the ability of Adient to close the transactions subject to the Yanfeng Agreement, the impact of tax reform legislation through the Tax Cuts and Jobs Act, uncertainties in U.S. administrative policy regarding trade agreements, tariffs and other international trade relations, the ability of Adient to effectively launch new business at forecasted and profitable levels, the ability of Adient to execute its turnaround plan, the ability of Adient to identify, recruit and retain key leadership, the ability of Adient to meet debt service requirements, the terms of financing, general economic and business conditions, the strength of the U.S. or other economies, automotive vehicle production levels, mix and schedules, energy and commodity prices, the availability of raw materials and component products, currency exchange rates and cancellation of or changes to commercial arrangements. Additional information regarding these and other risks related to Adient’s business that could cause actual results to differ materially from what is contained in the forward-looking statements is included in the section entitled "Risk Factors," contained in Item Part I, Item 1A of the which are incorporated herein by reference. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included in Part II, Item 8 of the Form 10-K. All information presented herein is based on Adient's fiscal calendar. Unless otherwise stated, references to particular years, quarters, months or periods refer to Adient's fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Adient assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

Overview

Adient is a global leader in the automotive seating supply industry with leading market positions in the Americas, Europe and China and maintains longstanding relationships with the largest global automotive original equipment manufacturers (OEMs). Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests, trim covers and fabrics. Adient is a global seat supplier with the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world. Adient also participates in the automotive interiors market, which includes production of instrument panels, floor consoles, door panels, overhead consoles, cockpit systems, decorative trim and other automotive interior products, primarily through its joint venture in China, Yanfeng Global Automotive Interior Systems Co., Ltd. (YFAI)

Adient designs, manufactures and markets a full range of seating systems and components for passenger cars, commercial vehicles and light trucks, including vans, pick-up trucks and sport/crossover utility vehicles. Adient operates in 220 wholly- and majority-owned manufacturing or assembly facilities, with operations in 33 countries. Additionally, Adient has partially-owned affiliates in China, Asia, Europe and North America. Through its global footprint, vertical integration and partnerships in China, Adient leverages its capabilities to drive growth in the automotive seating industry.

Adient plc | Form 10-Q | 33

Recent Developments Regarding COVID-19

The impact of the novel strain of the coronavirus identified in late 2019 (“COVID-19”) has grown throughout the world, including in all global and regional markets served by Adient. Governmental authorities have implemented numerous measures attempting to contain and mitigate the effects of COVID-19, including travel bans and restrictions, quarantines, social distancing orders, shelter in place orders and shutdowns of non-essential activities. Adient's manufacturing facilities are located in areas that have been affected by the pandemic. Adient's China facilities (including both consolidated and non-consolidated joint ventures) were effectively shut down during the lunar New Year festival (at the end of January) and did not return to operations until the end of March 2020. Currently, all of Adient's plants in China are operating and all of its customer plants in China have re-opened.

Beginning in late March 2020, Adient experienced the shutdown of effectively all of its facilities in the Americas and European regions coinciding with the shutdown of its customer facilities in those regions. Adient also experienced the shutdown of approximately 50% of its plants in Asia (outside China) during late March and early April. During May and June, production started to resume in all regions concurrent with Adient's customers resuming operations. As of June 30, 2020, the majority of Adient's plants have resumed production, but with production rates well below pre-pandemic levels.

It is likely that the global automotive industry will experience significantly lower demand for new vehicle sales as a result of the global economic slowdown caused by the COVID-19 pandemic because new vehicle sales are highly dependent on strong consumer confidence and low unemployment. Until consumers regain confidence in the markets and unemployment returns to lower levels, new vehicle sales will likely be significantly lower than historical and previously projected pre-pandemic sales levels.

Adient has been actively monitoring the global outbreak and spread of COVID-19 and taking steps to mitigate the potential risks to the Company posed by its spread and related circumstances and impacts. Adient continues to assess and update its business continuity plans in the context of this pandemic, including analyzing constraints at its suppliers. Adient has taken precautions to help keep its workforce healthy and safe, including establishing a Global Response Team, implementing strict travel restrictions, enforcing rigorous hygiene protocols, increasing sanitization efforts at all facilities, enacting visitor restrictions, social distancing, face covering expectations, and temperature and health screenings and implementing remote working arrangements for the vast majority of Adient's employees who work outside the plants.

Adient took significant measures to reduce its overall cash burn rate (defined as net cash outflow associated with operating the company) during the shutdown, including the furlough of direct/salary plant workers, reductions of salaries in all areas of the globe and retirement benefits for U.S. employees outside the plants, reduced/delayed capex spending to coincide with the resumption of production and effectively eliminating all discretionary spending. The actions to reduce and defer compensation were global initiatives and included 20% salary reductions in the U.S. beginning on March 23, 2020 (with up to 10% incremental reductions and deferrals taking effect on April 13, 2020) and running until June 30, 2020, salary reductions of up to 20% for certain employees in many of the countries outside of the U.S., CEO salary reduction and deferral until July 15, 2020, and a 20% Board fee reduction. Effective July 1, 2020, Adient offered certain employees, including Adient’s executive officers, RSU awards in lieu of 10-30% of salary and other compensatory benefits that are being foregone by each recipient from the time period beginning July 1, 2020 through June 30, 2021. The RSU awards will vest in two tranches, with one half of the awards vesting six months from the grant date, and the remaining half vesting one year from the grant date.

In addition to the significant measures taken to reduce and contain costs, Adient has taken recent action to provide additional liquidity, primarily including the draw down on its ABL revolving credit facility of $825 million at the end of March 2020 and the issuance of $600 million of senior secured notes due 2025 on April 20, 2020. Adient's ability to borrow against the ABL revolving credit facility is limited to its borrowing base, which consists primarily of accounts receivable, inventory and certain cash account balances at certain Adient subsidiaries. Such working capital account balances have decreased, as expected, during the third quarter of fiscal 2020 as a result of the production shutdown. Adient therefore repaid $646 million during the third quarter of fiscal 2020, resulting in $179 million outstanding and $155 million of availability under the ABL revolving credit facility as of June 30, 2020. During July 2020, Adient voluntarily repaid the outstanding balance of the ABL revolving credit balance.

The recent automotive production shutdown across most of the world has also significantly impacted Adient’s daily working capital. During the third quarter of fiscal 2020, Adient experienced significantly lower trade working capital balances (accounts receivable, inventory and accounts payable) due to the shutdown of production in the early part of the third quarter and resumption of production only toward the latter part of the quarter. Trade working capital was favorably impacted during the

Adient plc | Form 10-Q | 34

early part of the third quarter but was more than offset by the unfavorable impact to trade working capital during the latter part of the quarter. The continuing resumption of production in the fourth quarter is expected to have a favorable impact to trade working capital as Adient returns to a more stabilized production run rate.

Adient expects to close on the sale of its YFAI joint venture investment (as part of the broader YF China transactions announced on January 31, 2020 and as modified on June 24, 2020) by the end of FY2020, providing additional liquidity of approximately $334 million. Adient also expects to close on the sale of its fabrics business by the end of FY2020, providing additional liquidity of approximately $175 million. Both transactions are subject to customary closing conditions and regulatory approvals in certain jurisdictions. Adient cannot guarantee that the closing conditions contained in the respective purchase agreements related to the sale of YFAI or the sale of the fabrics business will be satisfied or waived, or that the sale of YFAI and/or the sale of the fabrics business will be completed within the respective expected timeframes, on the respective proposed terms, or at all.

Adient has also pursued, wherever it qualifies, governmental assistance during this time. For example, Adient has begun deferring the employer portion of FICA until FY2021 or beyond and deferring VAT payments. Adient is seeking to take advantage of all such assistance to either defer payments to government authorities or to receive cash to help defray operating costs. Adient cannot guarantee that it will continue to qualify for, or receive any of, the assistance that it is pursuing.

Finally, Adient’s Chinese joint ventures are expected to pay dividends to Adient during the fiscal year ending September 30, 2020 of approximately $280 million, of which approximately $250 million had been received as of June 30, 2020. Adient, however, cannot guarantee the collection of the remaining cash dividends from its non-consolidated joint ventures.

The spread of COVID-19 and the measures taken to restrain the spread of the virus have had, and will continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well beyond the containment of such outbreak. Adient cannot assure that the assumptions used to estimate its liquidity requirements will be correct because it has never previously experienced such a widespread cessation of its operations as it experienced in the third quarter of fiscal 2020. In addition, the magnitude, duration, speed and potential resurgence of the global pandemic is uncertain. Consequently, the impact on Adient's business, financial condition or longer-term financial or operational results are uncertain. Based on the actions it has taken and the assumptions regarding the impact of COVID-19, Adient believes that its current financial resources will be sufficient to fund the company's liquidity requirements for at least the next twelve months.

Global Automotive Industry

Adient conducts its business globally in the automotive industry, which is highly competitive and sensitive to economic, political and social factors in the various regions. In the third quarter of fiscal 2020, automotive light vehicle production on a global basis decreased significantly compared to the third quarter of fiscal 2019. The significant decrease in global light vehicle production during the first nine months of fiscal 2020 is primarily attributable to the impact of COVID-19, which caused the vast majority of global production to be suspended by OEM's, starting in China primarily during February and March 2020 followed by Americas, Europe and other Asian countries during March 2020. During May and June, production started to resume in all regions.

Light vehicle production levels by geographic region are provided below:


	Light Vehicle Production
	Three Months Ended June 30,					Nine Months Ended June 30,
(units in millions)	2020	Change	2019	2020	Change	2019
Global	12.0	(45.2)%	21.9	52.0	(23.3)%	67.8
North America	1.3	(69.0)%	4.2	8.9	(28.8)%	12.5
South America	0.2	(77.8)%	0.9	1.6	(36.0)%	2.5
Europe	2.1	(64.4)%	5.9	12.0	(29.0)%	16.9
China	6.0	9.1%	5.5	16.6	(10.8)%	18.6
Asia, excluding China, and Other	2.4	(55.6)%	5.4	12.9	(25.4)%	17.3

Source: IHS Automotive, July 2020

Adient plc | Form 10-Q | 35

Financial Results Summary

Significant aspects of Adient's financial results for the third quarter of fiscal 2020 include the following:

•Adient recorded net sales of $1,626 million for the third quarter of fiscal 2020, representing a decrease of $2,593 million or 61% when compared to the third quarter of fiscal 2019. Adient recorded net sales of $9,073 million for the first nine months of fiscal 2020, representing a decrease of $3,532 million, or 28% when compared to the first nine months of fiscal 2019. The decrease in net sales is primarily due to the significant operational interruptions caused by the COVID-19 pandemic which resulted in lower sales volumes across all regions.

•Gross profit was a loss of $153 million, or (9.4)% of net sales for the third quarter of fiscal 2020 compared to $211 million, or 5.0% of net sales for the third quarter of fiscal 2019. Gross profit was $347 million, or 3.8% of net sales for the first nine months of fiscal 2020 compared to $588 million, or 4.7% of net sales for the first nine months of fiscal 2019. Profitability, including gross profit as a percentage of net sales, was lower due to the impact of significantly lower sales volumes across all regions driven by the impact of COVID-19.

•Equity income was $48 million for the third quarter of fiscal 2020, compared to $64 million for the third quarter of fiscal 2019. The decrease is primarily attributable to the impact for the planned divestiture of YFAI ($15 million) and the non-cash impairment of Adient's YFAI investment ($6 million), partially offset by the resumption of production within Adient's affiliates in China. Equity loss was $57 million for the first nine months of fiscal 2020, compared to equity income of $209 million for the first nine months of fiscal 2019. The decrease on a year-to-date basis is primarily attributable to a $222 million non-cash impairment of Adient's YFAI investment and to the lower production volumes at Adient's China affiliates during the second and third quarters of fiscal 2020 due to the impact of COVID-19.

•Net loss attributable to Adient was $325 million for the third quarter of fiscal 2020, compared to $321 million of net loss attributable to Adient for the third quarter of fiscal 2019. The higher level of loss in the third quarter of fiscal 2020 is primarily attributable to the overall decrease of profitability in fiscal 2020 resulting from significantly lower volumes due to COVID-19 along with increased restructuring and impairment costs of $34 million and a $6 million non-cash impairment charge on Adient's YFAI investment in the current year, offset by a lower income tax provision for the third quarter of fiscal 2020 of $333 million due to prior year valuation allowance charges, and lower overall SG&A of $50 million. Net loss attributable to Adient for the first nine months of 2020 was $511 million, compared to a net loss attributable to Adient of $487 million during the first nine months of fiscal 2019. The year over year increase in net loss attributable to Adient is primarily due to the impact of having significantly lower volumes due to COVID-19 along with a one-time non-cash impairment charge of $222 million on Adient's YFAI investment, a $25 million loss on the sale of the RECARO business and deconsolidation of Adient Aerospace, a $27 million non-cash impairment charge related to long-lived assets in China, and overall higher net financing costs, partially offset by operating improvements and lower administrative costs and one-time charges in the prior year related to impairment in the seat structures and mechanism business and income tax charges to establish valuation allowances.

Adient plc | Form 10-Q | 36

Consolidated Results of Operations


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net sales	$	1,626	-61%	$	4,219	$	9,073	-28%	$	12,605
Cost of sales	1,779		-56%	4,008		8,726		-27%	12,017
Gross profit	(153)		> -100%	211		347		-41%	588
Selling, general and administrative expenses	115		-30%	165		407		-20%	511
Loss on business divestitures - net	—		n/a	—		25		n/a	—
Restructuring and impairment costs	49		> 100%	15		103		-35%	159
Equity income (loss)	48		-25%	64		(57)		> -100%	209
Earnings (loss) before interest and income taxes	(269)		> -100%	95		(245)		> -100%	127
Net financing charges	58		-3%	60		156		16%	135
Other pension expense (income)	(1)		> -100%	5		(5)		> -100%	3
Income (loss) before income taxes	(326)		> -100%	30		(396)		> 100%	(11)
Income tax provision (benefit)	5		-99%	338		75		-82%	412
Net income (loss)	(331)		-7%	(308)		(471)		-11%	(423)
Income (loss) attributable to noncontrolling interests	(6)		> -100%	13		40		-38%	64
Net income (loss) attributable to Adient	$	(325)	-1%	$	(321)	$	(511)	-5%	$	(487)

Net Sales


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net sales	$	1,626	-61%	$	4,219	$	9,073	-28%	$	12,605

Net sales decreased by $2,593 million, or 61%, in the third quarter of fiscal 2020 as compared to the third quarter of fiscal 2019 primarily due to lower volumes in all regions attributable to the significant interruption to Adient's global operations caused by COVID-19, the unfavorable impact of foreign currency ($106 million), and the impact of divestitures primarily related to RECARO ($45 million). Refer to the segment analysis below for a discussion of segment net sales.

Net sales decreased by $3,532 million, or 28%, in the first nine months of fiscal 2020 as compared to the first nine months of fiscal 2019 primarily due to the significant operational interruptions related to COVID-19 starting in the second quarter of fiscal 2020 which resulted in lower sales volumes across all regions, unfavorable foreign currency impact ($232 million), and the impact of divestitures primarily related to RECARO ($83 million), partially offset by favorable commercial settlements and net pricing adjustments, including material economics, net of recoveries. Refer to the segment analysis below for a discussion of segment net sales.

Cost of Sales / Gross Profit


	Three Months Ended June 30,											Nine Months Ended June 30,
(in millions)	2020			Change	2019			2020			Change	2019
Cost of sales	$	1,779		-56%	$	4,008		$	8,726		-27%	$	12,017
Gross profit	$	(153)		> -100%	$	211		$	347		-41%	$	588
% of sales	(9.4)		%		5.0		%	3.8		%		4.7		%

Adient plc | Form 10-Q | 37

Cost of sales decreased by $2,229 million, or 56%, and gross profit decreased by $364 million, or 173%, in the third quarter of fiscal 2020 as compared to the third quarter of fiscal 2019. The year over year decrease in cost of sales was primarily due to the decrease in sales volumes along with overall business performance improvements, the favorable impact of foreign currency ($92 million), and the impact of divestitures primarily related to RECARO ($46 million). Gross profit was negatively impacted by the lower sales volume due to the COVID-19 impact, partially offset by the impact of business performance improvements including lower launch inefficiencies, and reductions in operational waste and freight along with favorable commercial settlements and net pricing adjustments. Refer to the segment analysis below for a discussion of segment profitability.

Cost of sales decreased by $3,291 million, or 27% and gross profit decreased by $241 million, or 41%, in the first nine months of fiscal 2020 as compared to the first nine months of fiscal 2019. The cost of sales year over year decrease is primarily attributable to lower sales volumes along with overall business performance improvements, the favorable impact of foreign currency ($212 million), and impact of divestitures primarily related to RECARO ($85 million). Gross profit was negatively impacted by the lower sales volume due to the COVID-19 impact, partially offset by the impact of business performance improvements including lower launch inefficiencies, and reductions in operational waste and freight along with favorable commercial settlements and net pricing adjustments. Refer to the segment analysis below for a discussion of segment profitability.

Selling, General and Administrative Expenses


	Three Months Ended June 30,											Nine Months Ended June 30,
(in millions)	2020			Change	2019			2020			Change	2019
Selling, general and administrative expenses	$	115		-30%	$	165		$	407		-20%	$	511
% of sales	7.1		%		3.9		%	4.5		%		4.1		%

Selling, general and administrative expenses (SG&A) decreased by $50 million, or 30% in the third quarter of fiscal 2020 as compared to the third quarter of fiscal 2019. The year over year decrease in SG&A is attributable to lower overall administrative and engineering spending of $32 million, including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual SG&A run rate, prior year Adient Aerospace and RECARO administrative costs of $13 million, and lower share based compensation expense of $1 million, partially offset by higher transaction costs related to the planned divestitures of YFAI and the fabrics business of $2 million. Refer to the segment analysis below for a discussion of segment profitability.

Selling, general and administrative expenses (SG&A) decreased by $104 million, or 20% in the first nine months of fiscal 2020 as compared to the first nine months of fiscal 2019. SG&A was favorably impacted by lower overall administrative and engineering spending of $71 million, including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual SG&A run rate, prior year Adient Aerospace and RECARO administrative costs of $29 million, and lower share based compensation expense of $8 million, partially offset by higher transaction costs related to the planned divestiture of YFAI and the fabrics business of $8 million. Refer to the segment analysis below for a discussion of segment profitability.

Loss on Business Divestitures - net


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Loss on business divestitures - net	$	—	n/a	$	—	$	25	n/a	$	—

 The loss on business divestitures for the first nine months of 2020 is comprised of a $21 million loss on the sale of RECARO automotive high performance seating and a $4 million loss on the deconsolidation of Adient Aerospace. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for information related to these divestitures.

Adient plc | Form 10-Q | 38

Restructuring and Impairment Costs


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Restructuring and impairment costs	$	49	> 100%	$	15	$	103	-35%	$	159

Restructuring and impairment costs were higher by $34 million during the third quarter of fiscal 2020 due primarily to one-time non-cash impairment charges of long-lived assets in China ($27 million), and lower by $56 million during the nine months ended June 30, 2020 due primarily to one-time non-cash impairment charges in the prior year related to the seat structures and mechanisms business ($66 million) and to overall lower levels of restructuring actions recorded in 2020. Refer to Note 13, "Restructuring and Impairment Costs," of the notes to the consolidated financial statements for information related to Adient's restructuring plans.

Equity Income (Loss)


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Equity income (loss)	$	48	-25%	$	64	$	(57)	> -100%	$	209

Equity income was $48 million for the third quarter of fiscal 2020, compared to $64 million of income in the third quarter of fiscal 2019. The decrease is primarily attributable to the impact for the planned divestiture of YFAI ($15 million) and the non-cash impairment of Adient's YFAI investment ($6 million), partially offset by the resumption of production within Adient's affiliates in China.

Equity loss was $57 million for the first nine months of fiscal 2020, which is $266 million lower compared to the first nine months of fiscal 2019. The change is primarily attributable to the $222 million non-cash impairment charge recorded during the first nine months of fiscal 2020 related to Adient's YFAI investment and the impact from the planned divestiture of YFAI ($19 million) along with lower production volumes within Adient's affiliates in China due to the impact of COVID-19, partially offset by $10 million of benefits from tax credits at various China affiliates that are not expected to recur.

Net Financing Charges


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net financing charges	$	58	-3%	$	60	$	156	16%	$	135

Net financing charges decreased in the third quarter of fiscal 2020 as compared to the third quarter of fiscal 2019 due to a $13 million one-time charge in the prior year of deferred financing fees in conjunction with the debt refinancing in the third quarter of fiscal 2019, partially offset by higher levels of outstanding debt and higher average interest rates in the current year. Net financing charges increased in the nine months ended June 30, 2020 as compared to the nine months ended June 30, 2019 due to higher levels of outstanding debt and to higher average interest rates in the current year, partially offset by the $13 million one-time charge of deferred financing fees in the prior year.

Other Pension Expense (Income)


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Other pension expense (income)	$	(1)	> -100%	$	5	$	(5)	> -100%	$	3

Other pension expense (income) for the three and nine months ended June 30, 2020 included a $2 million pension settlement expense related to the settlement of two plans in the United States. Other pension expense (income) for the three and nine months ended June 30, 2019 included a $6 million mark-to-market expense related to the remeasurement of a United Kingdom

Adient plc | Form 10-Q | 39

pension plan. Refer to Note 12, "Retirement Plans," of the notes to the consolidated financial statements for information related to the non-service components of Adient's net periodic pension costs.

Income Tax Provision


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Income tax provision (benefit)	$	5	-99%	$	338	$	75	-82%	$	412

During the third quarter of fiscal 2020 income tax expense of $5 million was recognized rather than a tax benefit that would have been recognized by applying the statutory rate of 12.5% against pre-tax losses, primarily due to the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances, partially offset by a $5 million tax benefit related to the impairment charge recorded in the Asia segment related to customer relationship intangible assets. The third quarter of fiscal 2019 income tax expense of $338 million primarily resulted from an income tax charge of $254 million to establish valuation allowances in Luxembourg and the United Kingdom and an income tax charge of $48 million to recognize the year-to-date impact of Adient's updated annualized tax rate, driven by the valuation allowances recorded in the third quarter of fiscal 2019.

During the first nine months of fiscal 2020 income tax expense of $75 million was recognized rather than a tax benefit that would have been recognized by applying the statutory rate of 12.5% against pre-tax losses, primarily due to the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances and $6 million tax expense associated primarily with foreign currency remeasurement of Mexican peso deferred tax assets, partially offset by a $4 million tax benefit associated with the impairment of Adient’s YFAI investment and a $5 million tax benefit related to the impairment charge recorded in the Asia segment related to customer relationship intangible assets. The first nine months of fiscal 2019 income tax expense of $412 million resulted primarily from establishing valuation allowances in Luxembourg, Poland, and the United Kingdom and the impact of recognizing no tax benefit for losses in jurisdictions with valuation allowances, partially offset by a tax rate change at a consolidated affiliate in China.

Income Attributable to Noncontrolling Interests


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Income (loss) attributable to noncontrolling interests	$	(6)	> -100%	$	13	$	40	-38%	$	64

The decrease in income attributable to noncontrolling interests for the three and nine months ended June 30, 2020 is primarily attributable to lower income resulting from lower volumes, caused by COVID-19 at certain Seating affiliates in varying jurisdictions in the current periods.

Net Income (Loss) Attributable to Adient


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net income (loss) attributable to Adient	$	(325)	-1%	$	(321)	$	(511)	-5%	$	(487)

Net loss attributable to Adient was $325 million for the third quarter of fiscal 2020 compared to $321 million of net loss attributable to Adient for the third quarter of fiscal 2019. The higher level of net loss in the third quarter of fiscal 2020 is primarily attributable to the overall decrease in profitability in fiscal 2020 resulting from significantly lower volumes due to COVID-19 along with increased restructuring and impairment costs of $34 million and a $6 million non-cash impairment charge on Adient's YFAI investment in the current year, offset by a lower income tax provision for the third quarter of fiscal 2020 of $333 million due to a prior year valuation allowance change and lower overall SG&A of $50 million.

Net loss attributable to Adient for the first nine months of 2020 was $511 million, compared to a net loss attributable to Adient of $487 million during the first nine months of fiscal 2019. The year over year increase in net loss attributable to Adient is

Adient plc | Form 10-Q | 40

primarily due to the impact of having significantly lower volumes due to COVID-19 along with a one-time non-cash impairment charge of $222 million on Adient's YFAI investment, a $25 million loss on the sale of the RECARO business and deconsolidation of Adient Aerospace, and overall higher net financing costs, offset by higher profitability levels in fiscal 2020 resulting from operating improvements and lower administrative costs and one-time charges in the prior year related to impairment in the seat structures and mechanism business of $66 million and income tax charges to establish valuation allowances of $43 million.

Comprehensive Income (Loss) Attributable to Adient


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Comprehensive income (loss) attributable to Adient	$	(293)	14%	$	(341)	$	(600)	(32)%	$	(455)

Comprehensive loss attributable to Adient was $293 million for the third quarter of fiscal 2020 compared to $341 million of comprehensive loss for the third quarter of fiscal 2019. The decreased level of comprehensive loss attributable to Adient in the third quarter of fiscal 2020 is primarily due to the favorable impact in foreign currency translation adjustments ($41 million) primarily related to Chinese yuan, favorable impact in realized and unrealized losses on derivatives ($19 million), and the decrease in comprehensive income attributable to noncontrolling interests ($11 million), offset by higher levels of net loss ($23 million).

Comprehensive loss attributable to Adient was $600 million for the first nine months of fiscal 2020 compared to a comprehensive loss attributable to Adient of $455 million for the first nine months of fiscal 2019. The increased level of comprehensive loss attributable to Adient in the first nine months of fiscal 2020 is primarily due to the unfavorable impact in foreign currency translation adjustments resulting from overall weakening of emerging market currencies ($98 million), unfavorable impact in realized and unrealized losses on derivatives ($29 million), and the unfavorable impact of higher levels of net loss ($48 million), partially offset by the decrease in comprehensive income attributable to noncontrolling interests ($29 million).

Segment Analysis

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, qualified restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The results for the three months and nine months ended June 30, 2020 presented below are not necessarily indicative of full-year results, particularly for fiscal 2020 given the unprecedented situation Adient is currently facing with the COVID-19 pandemic and the related significant interruption the impacts of the pandemic is having on Adient's operations. Refer to the Recent Developments Regarding COVID-19 section earlier in Item 2. and to Part II, Item 1.A. Risk Factors, for additional information related to the COVID-19 impacts on Adient.

Financial information relating to Adient's reportable segments is as follows:

Adient plc | Form 10-Q | 41


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Net Sales
Americas	$	593	$	2,010	$	4,093	$	5,860
EMEA	698		1,752		3,750		5,170
Asia	346		530		1,362		1,779
Eliminations	(11)		(73)		(132)		(204)
Total net sales	$	1,626	$	4,219	$	9,073	$	12,605


	Three Months Ended June 30,						Nine Months Ended June 30,
(in millions)	2020		2019		2020		2019
Adjusted EBITDA
Americas	$	(83)	$	69	$	117	$	146
EMEA	(94)		53		17		114
Asia	71		110		311		387
Corporate-related costs ⁽¹⁾	(16)		(27)		(59)		(75)
Restructuring and impairment costs ⁽²⁾	(49)		(15)		(103)		(159)
Purchase accounting amortization ⁽³⁾	(9)		(11)		(30)		(32)
Restructuring related charges ⁽⁴⁾	(5)		(5)		(17)		(27)
Loss on business divestitures - net ⁽⁵⁾	—		—		(25)		—
Impairment of nonconsolidated partially-owned affiliate ⁽⁶⁾	(6)		—		(222)		—
Depreciation	(67)		(68)		(214)		(205)
Stock based compensation	(7)		(8)		(8)		(16)
Other items ⁽⁷⁾	(4)		(3)		(12)		(6)
Earnings (loss) before interest and income taxes	(269)		95		(245)		127
Net financing charges	(58)		(60)		(156)		(135)
Other pension income (expense)	1		(5)		5		(3)
Income (loss) before income taxes	$	(326)	$	30	$	(396)	$	(11)

Notes:

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal, finance and marketing.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring related charges for costs that are directly attributable to restructuring activities, but do not meet the definition of restructuring under ASC 420 along with restructuring costs at partially owned affiliates recorded within equity income.

Adient plc | Form 10-Q | 42

(6) Reflects the non-cash impairment of Adient's YFAI investment as described in Note 3, "Acquisitions and Divestitures," of the notes to consolidated financial statements.

Americas


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net sales	$	593	-70%	$	2,010	$	4,093	-30%	$	5,860
Adjusted EBITDA	$	(83)	> -100%	$	69	$	117	-20%	$	146

Net sales decreased during the third quarter of fiscal 2020 by $1,417 million due to lower production volumes ($1,376 million), resulting primarily from the operational shutdowns during the three months ended June 30, 2020 in response to the COVID-19 pandemic, along with the unfavorable impact of foreign currency ($29 million), and the unfavorable impact of the RECARO divestiture ($14 million), partially offset by the impact of favorable commercial settlements and net pricing adjustments ($2 million).

Adjusted EBITDA decreased during the third quarter of fiscal 2020 by $152 million due to lower production volumes ($230 million), lower equity income ($1 million), and the unfavorable impact of foreign currency ($5 million), partially offset by the impact of operational performance improvements ($36 million), lower administrative and engineering expense ($33 million) including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual run rate, the favorable impact of Adient Aerospace deconsolidation and RECARO divestiture ($7 million), favorable net material and pricing adjustments ($5 million) and favorable material economics, net of recoveries ($3 million).

Net sales decreased during the first nine months of fiscal 2020 by $1,767 million due to lower production volumes ($1,713 million) resulting primarily from the operational shutdowns that started in March 2020 in response to the COVID-19 pandemic as well as $55 million attributable to the GM labor strike during the first quarter of fiscal 2020, along with the unfavorable impact of foreign currency ($48 million), and the unfavorable impact of the RECARO divestiture ($27 million), partially offset by the favorable impact of commercial settlements and net pricing adjustments ($21 million).

Adjusted EBITDA decreased during the first nine months of fiscal 2019 by $29 million due to lower production volumes ($274 million), lower equity income ($2 million), and unfavorable impact of foreign currency ($3 million), partially offset by the impact of operational performance improvements ($88 million), lower administrative and engineering expense ($78 million)

including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual run rate, the favorable impact of Adient Aerospace deconsolidation and RECARO divestiture ($19 million), favorable net material and pricing adjustments ($46 million) and favorable material economics, net of recoveries ($14 million).

EMEA


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net sales	$	698	-60%	$	1,752	$	3,750	-27%	$	5,170
Adjusted EBITDA	$	(94)	> -100%	$	53	$	17	-85%	$	114

Adient plc | Form 10-Q | 43

Net sales decreased during the third quarter of fiscal 2020 by $1,054 million due to lower production volumes ($963 million) resulting primarily from the operational shutdowns during the three months ended June 30, 2020 in response to the COVID-19 pandemic, the unfavorable impact of foreign currency ($68 million), the unfavorable impact of divestitures primarily related to RECARO ($12 million), and the unfavorable impact of commercial settlements and net pricing adjustments ($11 million).

Adjusted EBITDA decreased during the third quarter of fiscal 2020 by $147 million due to lower production volumes ($175 million) and the unfavorable impact of foreign currency ($5 million) and unfavorable material economics, net of recoveries ($9 million), and lower equity income ($4 million), partially offset by operational performance improvements ($20 million), lower administrative and engineering expense ($21 million) including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual run rate, favorable net material and pricing adjustments ($3 million), and the favorable impact of the RECARO divestiture ($2 million).

Net sales decreased during the first nine months of fiscal 2020 by $1,420 million due to lower production volumes ($1,225 million) resulting primarily from the operational shutdowns that started in March 2020 in response to the COVID-19 pandemic along with the unfavorable impact of foreign currency ($181 million), the unfavorable impact of the RECARO divestiture ($25 million) and the unfavorable impact of material economics ($10 million), partially offset by favorable commercial settlements and net pricing adjustments ($21 million).

Adjusted EBITDA decreased during the first nine months of fiscal 2020 by $97 million due to lower volumes ($219 million), and the unfavorable impact of foreign currency ($11 million), unfavorable material economics, net of recovery ($16 million), and lower equity income ($3 million), partially offset by operational performance improvements ($55 million), lower administrative and engineering expense ($40 million) including lower levels of incentive compensation and discretionary spending which are not expected to recur as part of the annual run rate, favorable net material and pricing adjustments ($54 million), and the favorable impact of divestitures primarily related to RECARO ($3 million).

Asia


	Three Months Ended June 30,								Nine Months Ended June 30,
(in millions)	2020		Change	2019		2020		Change	2019
Net sales	$	346	-35%	$	530	$	1,362	-23%	$	1,779
Adjusted EBITDA	$	71	-35%	$	110	$	311	-20%	$	387

Net sales decreased during the third quarter of fiscal 2020 by $184 million due to lower production volumes ($157 million) primarily resulting from the operational shutdowns in Asia during the three months ended June 30, 2020 in response to the COVID-19 pandemic, the unfavorable impact of the RECARO divestiture ($12 million), the unfavorable impact of foreign currency ($13 million) and the unfavorable impact of commercial settlements and net pricing adjustments ($2 million).

Adjusted EBITDA decreased during the third quarter of fiscal 2020 by $39 million due to overall lower production volumes ($26 million) as a result of the COVID-19 pandemic, the unfavorable impact of foreign currency ($7 million), the unfavorable impact of the planned YFAI divestiture ($15 million), higher administrative and engineering expense ($4 million), the unfavorable impact of the RECARO divestiture ($2 million), and unfavorable net material and pricing adjustments ($2 million), partially offset by operational performance improvements ($1 million), and higher equity income from China seating affiliates ($16 million).

Net sales decreased during the first nine months of fiscal 2020 by $417 million due to lower production volumes ($397 million) primarily resulting from the operational shutdowns in China and in other Asia countries during the nine months ended June 30, 2020 in response to the COVID-19 pandemic, the unfavorable impact of the RECARO divestiture ($25 million), the unfavorable impact of foreign currency ($11 million), and the unfavorable impact of material economics ($3 million), partially offset by the favorable impact of commercial settlements and net pricing adjustments ($16 million).

Adjusted EBITDA decreased during the first nine months of fiscal 2020 by $76 million due to the impact of lower production volumes ($56 million), lower equity income from China seating affiliates ($5 million) as a result of the operational shutdowns of Adient's affiliates during the second quarter of fiscal 2020 in response to the COVID-19 pandemic, the unfavorable impact of the planned YFAI divestiture ($19 million), unfavorable material economics, net of recoveries ($3 million), the unfavorable impact of foreign currency ($11 million), higher administrative and engineering costs ($4 million), and the unfavorable impact

Adient plc | Form 10-Q | 44

of the RECARO divestiture ($6 million), partially offset by operational performance improvements ($5 million) and favorable net material and pricing adjustments ($23 million).

Liquidity and Capital Resources

Adient's primary liquidity needs are to fund general business requirements, including working capital, capital expenditures, restructuring costs and debt service requirements. Adient's principal sources of liquidity are cash flows from operating activities, the revolving credit facility and other debt issuances, and existing cash balances. Adient actively manages its working capital and associated cash requirements and continually seeks more effective uses of cash. Working capital is highly influenced by the timing of cash flows associated with sales and purchases, and therefore can be difficult to manage at times. See below and refer to Note 8, "Debt and Financing Arrangements," of the notes to consolidated financial statements for discussion of financing arrangements. Following the first quarter of fiscal 2019 dividend payout, Adient has suspended future dividends. Refer to the "Recent Developments Regarding COVID-19" section for additional information on short term liquidity measures implemented in response to the COVID-19 pandemic.

Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintains an asset-based revolving credit facility (the “ABL Credit Facility”), which provides for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity. The ABL Credit Facility will mature on May 6, 2024, subject to a springing maturity date 91 days earlier if certain amounts remain outstanding at that time under the Term Loan B Agreement (defined below). Interest is payable on the ABL Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate plus an applicable margin of 1.50% to 2.00%. Adient will pay a commitment fee of 0.25% to 0.375% on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the ABL Credit Facility then in effect. Subject to certain conditions, the ABL Credit Facility may be expanded by up to $250 million in additional commitments. Loans under the ABL Credit Facility may be denominated, at the option of Adient, in U.S. dollars, Euros, Pounds Sterling or Swedish Kroner. The ABL Credit Agreement is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. On March 26, 2020, Adient borrowed $825 million in principal amount under the agreement. Adient repaid $646 million during the third quarter of fiscal 2020, resulting in $179 million outstanding at June 30, 2020, which is recorded as short-term debt. As of June 30, 2020, Adient's availability under this facility was $155 million (net of $107 million of letters of credit).

Adient plc | Form 10-Q | 45

On April 20, 2020, Adient US offered $600 million (net proceeds of $591 million) aggregate principal amount of 9.00% Senior First Lien Notes due 2025. These notes will mature on April 15, 2025, provided that if AGH has not refinanced (or otherwise redeemed) in whole its outstanding 3.50% unsecured notes due 2024 or any refinancing indebtedness thereof that matures earlier than 91 days prior to the maturity date of the Senior First Lien Notes due 2025 on or prior to May 15, 2024, these notes will mature on May 15, 2024. Interest on these notes will be paid on April 15 and October 15 each year, beginning on October 15, 2020. These notes contain covenants that are usual and customary, similar to the covenants on the Senior First Lien Notes due 2026 as described above.

As discussed in the “Recent Developments Regarding COVID-19” section, the spread of COVID-19 and the measures taken to restrain the spread of the virus have had, and will continue to have, a material negative impact on Adient's financial results and liquidity, and such negative impact may continue well beyond the containment of such outbreak. Adient cannot assure that its assumptions used to estimate the liquidity requirements will be correct because it has never previously experienced such a widespread cessation of its operations as it experienced in the third quarter of fiscal 2020. In addition, the magnitude, duration, speed and potential resurgence of the global pandemic is uncertain. Consequently, the impact on Adient's business, financial condition or longer-term financial or operational results is uncertain. Based on the actions it has taken and its assumptions regarding the impact of COVID-19, Adient believes that its current financial resources will be sufficient to fund its liquidity requirements for at least the next twelve months.

Sources of Cash Flows


	Nine Months Ended June 30,
(in millions)	2020		2019
Cash provided (used) by operating activities	$	(272)	$	306
Cash provided (used) by investing activities	(280)		(278)
Cash provided (used) by financing activities	679		300
Capital expenditures	(258)		(350)

Operating Cash Flows: Cash flows from operating activities decreased year over year primarily as a result of lower profitability and overall unfavorable changes to working capital, primarily including unfavorable changes to accounts payable partially offset by favorable changes to accounts receivable.

Investing Cash Flows: The increase in cash used by investing activities is primarily attributable to prior year proceeds of $65 million from the sale of assets, including the sale of Detroit, Michigan properties and an airplane, and a current year $37 million cash outflow related to the deconsolidation of Adient Aerospace, partially offset by a year over year decrease in capital expenditures ($92 million).

Financing Cash Flows: The increase in cash provided by financing activities is primarily attributable to the net $179 million draw down of the ABL revolver as of June 30, 2020, the $600 million of proceeds from the issuance of 9.00% Senior Notes (due 2025) in April 2020, and by non-recurring cash dividends paid in the prior year ($26 million) to shareholders, partially offset by higher levels of cash dividends paid to noncontrolling interest ($14 million) and prior year cash received related to the formation of the Adient Aerospace consolidated joint venture ($28 million).

Capital expenditures: Capital expenditures decreased year over year based on timing of program spend on product launches and tightening controls around overall spending.

Adient plc | Form 10-Q | 46

Working capital


(in millions)	June 30, 2020		September 30, 2019
Current assets	$	3,459	$	4,116
Current liabilities	3,083		3,835
Working capital	$	376	$	281

The increase in working capital of $95 million is primarily attributable to lower levels of accounts payable as of June 30, 2020 offset by lower levels of accounts receivable and inventory. Also contributing to the higher levels of working capital is the recognition of lease liabilities (current lease liability of $88 million at June 30, 2020 impacting working capital) occurring upon adoption of the new lease accounting standard in the first quarter of fiscal 2020.

Restructuring Costs

During fiscal 2020, Adient committed to a restructuring plan ("2020 Plan") of $86 million that was offset by $10 million of prior year underspend. Of the restructuring costs recorded, $15 million relates to the Americas segment, $62 million relates to the EMEA segment and $9 million relates to the Asia segment. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2020 restructuring plan will reduce annual operating costs by approximately $85 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 35%-40% will result in net savings. The restructuring actions are expected to be substantially completed by fiscal 2022.

During fiscal 2019, Adient committed to a restructuring plan ("2019 Plan") of $105 million. Of the restructuring costs recorded, $81 million relates to the EMEA segment, $16 million relates to the Americas segment and $8 million relates to the Asia segment. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions. Also recorded in fiscal 2019 was $16 million of prior year underspend, a $9 million increase to a prior year reserve and $6 million of recoveries from a customer related to previous restructuring charges. This is the total amount expected to be incurred for this restructuring plan. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2019 restructuring plan will reduce annual operating costs by approximately $109 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 35-40% will result in net savings. The restructuring actions are expected to be substantially completed by fiscal 2021.

In fiscal 2018, Adient committed to a restructuring plan ("2018 Plan") of $71 million that was offset by $25 million of prior year underspend. Of the restructuring costs recorded, $52 million relates to the EMEA segment, $10 million relates to the Asia segment and $9 million relates to the Americas segment. In fiscal 2019 there was adjustment to this plan which resulted in additional $9 million of charges. This is the total amount expected to be incurred for this restructuring plan. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2018 restructuring plan will reduce annual operating costs by approximately $65 million, which is primarily the result of lower costs of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 55%-60% will result in net savings. Adient partially achieved these savings in fiscal year 2019.

In fiscal 2017, Adient committed to a restructuring plan ("2017 Plan") and recorded $46 million of restructuring and impairment costs in the consolidated statements of income. Of the restructuring costs recorded, $34 million relates to the EMEA segment, $7 million relates to the Americas segment and $5 million relates to the Asia segment. This is the total amount expected to be incurred for this restructuring plan. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions and plant closures. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2017 restructuring plan will reduce annual operating costs by approximately $40 million, which is primarily the result of lower cost of sales and selling, general and administrative expenses due to reduced employee-related costs, of which approximately 55%-60% will result in net savings. Adient partially achieved these savings in fiscal years 2017, 2018 and 2019. The restructuring actions are expected to be substantially complete in fiscal 2021.

In fiscal 2016, Adient committed to a restructuring plan ("2016 Plan") and recorded $332 million of restructuring and impairment costs in the consolidated statements of income. Of the restructuring and impairment costs recorded, $298 million related to the EMEA segment, $32 million related to the Americas segment and $2 million related to the Asia segment. This is

Adient plc | Form 10-Q | 47

the total amount expected to be incurred for this restructuring plan. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions, plant closures and asset impairments. Adient currently estimates that upon completion of the restructuring actions, the fiscal 2016 restructuring plan will reduce annual operating costs by approximately $145 million, which is primarily the result of lower cost of sales and selling, general and administrative expenses due to reduced employee-related costs and depreciation expense, of which approximately 75%-80% will result in net savings. Adient partially achieved these savings in fiscal years 2016 through 2019.

Off-Balance Sheet Arrangements and Contractual Obligations

There have been no material changes to the off-balance sheet arrangements and contractual obligations disclosed in Adient's Annual Report on Form 10-K for the year ended September 30, 2019.

Effects of Inflation and Changing Prices

The effects of inflation have not been significant to Adient's results of operations in recent years. Generally, Adient has been able to implement operating efficiencies to sufficiently offset cost increases, which have been moderate.

Critical Accounting Estimates and Policies

See "Critical Accounting Estimates and Policies" under the heading "Item 7" of Adient's Annual Report on Form 10-K for the year ended September 30, 2019, for a discussion of critical accounting estimates and policies. There have been no material changes to Adient's critical accounting estimates and policies during the three months ended June 30, 2020.

New Accounting Pronouncements

See Note 1, "Basis of Presentation and Summary of Significant Accounting Policies," of the notes to consolidated financial statements for a discussion of new accounting pronouncements.

Other Information

Not applicable

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

As of June 30, 2020, Adient had not experienced any adverse changes in market risk exposures that materially affected the quantitative and qualitative disclosures presented in Adient's Annual Report on Form 10-K for the year ended September 30, 2019.


Item 4.			Controls and Procedures

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, Adient's principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms.

Adient plc | Form 10-Q | 48

Changes in Internal Control over Financial Reporting

There were no changes in internal control over financial reporting during the three months ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Adient plc | Form 10-Q | 49


PART II - OTHER INFORMATION

Item 1.

Legal Proceedings

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Adient accrues for potential liabilities in a manner consistent with accounting principles generally accepted in the United States, that is, when it is probable a liability has been incurred and the amount of the liability is reasonably estimable.

Information with respect to this item may be found in Note 17, "Commitments and Contingencies," of the notes to consolidated financial statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

Additional information on Adient's commitments and contingencies can be found in Adient's Annual Report on Form 10-K for its fiscal year ended September 30, 2019.

Item 1A.

Risk Factors

There are no material changes from the risk factors as previously disclosed in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2019, except that Adient has updated the below risk factors to reflect recent developments. The following risk factor updates supersede the corresponding risk factors previously reported in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2019.

Adient's financial condition and results of operations have been, and are expected to continue to be, adversely affected by the recent coronavirus outbreak.

The global outbreak of COVID-19 has caused a material adverse effect on the level of economic activity around the world, including in all markets served by Adient. In response to this outbreak, the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations. Adient has implemented numerous measures attempting to manage and mitigate the effects of the virus. While the Company has implemented programs to mitigate the impact of these measures on the results of operations, there can be no assurance that these programs will be successful. Adient cannot predict the degree to, or the time period over, which its sales and operations will be affected by this outbreak and preventative measures, and the effects could be material.

The COVID-19 pandemic poses the risk that Adient or its affiliates and joint ventures, employees, suppliers, customers and others may be restricted or prevented from conducting business activities for indefinite or intermittent periods of time, including as a result of employee health and safety concerns, shutdowns, shelter in place orders, travel restrictions and other actions and restrictions that may be requested or mandated by governmental authorities. For example, the Company experienced a temporary shutdown of its facilities in the second quarter of fiscal 2020 in China as a result of government-mandated actions to control the spread of COVID-19. Additionally, beginning in late March 2020, the Company experienced a temporary shutdown of effectively all of its facilities in the Americas and European regions coinciding with the shutdown of its customer facilities in these regions. Further, certain government orders related to COVID-19 mitigation efforts may restrict Adient's ability to operate its business and may impact the financial condition and results of operations. Finally, while other of its facilities have been designated by customers as an essential business to its customers’ business in jurisdictions in which facility closures have been mandated, the Company can give no assurance that this will not change in the future or that businesses will continue to be classified as essential in each of the jurisdictions in which Adient operates.

Additionally, restrictions on the Company's access to its manufacturing facilities or on support operations or workforce, or similar limitations for its distributors and suppliers, could continue to limit customer demand and/or the Company's capacity to meet customer demand and have a material adverse effect on the business, financial condition and results of operations. In addition, Adient has modified its business practices (including employee travel, employee work locations, and cancellation of

Adient plc | Form 10-Q | 50

physical participation in meetings, events and conferences), and it may take further actions as may be required by government authorities, for the continued health and safety of the employees, or that the Company otherwise determines are in the best interests of the employees, customers, partners, and suppliers. Further, the Company has experienced, and may continue to experience, disruptions or delays in its supply chain as a result of such actions, which is likely to result in higher supply chain costs to Adient in order to maintain the supply of materials and components for the products.

The Company's management of the impact of COVID-19 has and will continue to require significant investment of time from its management and employees, as well as resources across the global enterprise. The focus on managing and mitigating the impacts of COVID-19 on the business may cause the Company to divert or delay the application of its resources toward other or new initiatives or investments, which may cause a material adverse impact on the results of operations.

Adient may also experience impacts from market downturns and changes in consumer behavior related to pandemic fears and impacts on its workforce as a result of COVID-19. The Company has experienced a significant decline in demand from its customers as a result of the impact of efforts to contain the spread of COVID-19. In addition, customers may choose to delay or abandon projects on which the Company provides products and/or services in response to the adverse impact of COVID-19 and the measures to contain its spread have had on the global economy.

Further, the impacts of COVID-19 have caused significant uncertainty and volatility in the credit markets. Adient relies on the credit markets to provide it with liquidity to operate and grow its businesses beyond the liquidity that operating cash flows provide. If the Company's access to capital were to become significantly constrained, or if costs of capital increased significantly due to the impact of COVID-19 including, volatility in the capital markets, a reduction in Adient's credit ratings or other factors, then the financial condition, results of operations and cash flows could be materially adversely affected.

If the COVID-19 pandemic becomes more pronounced in the markets in which the Company or its automotive industry customers operate, or there is a resurgence in the virus in markets currently recovering from the spread of COVID-19, then the Company's operations in areas impacted by such events could experience further materially adverse financial impacts due to market changes and other resulting events and circumstances. The extent to which the COVID-19 outbreak continues to impact the Company's financial condition will depend on future developments that are highly uncertain and cannot be predicted, including new government actions or restrictions, new information that may emerge concerning the severity of COVID-19, the longevity of COVID-19 and the impact of COVID-19 on economic activity To the extent the COVID-19 pandemic materially adversely affects the Company's business and financial results, it may also have the effect of significantly heightening many of the other risks associated with the Company's business and indebtedness, including those described in the most recent Annual Report on Form 10-K for the year ended September 30, 2019.

The COVID-19 pandemic presents significant challenges to Adient's liquidity.

Adient's continued access to sources of liquidity depends on multiple factors, including global economic conditions, the COVID-19 pandemic’s effects on its customers and their production rates, the condition of global financial markets, the availability of sufficient amounts of financing, its operating performance and credit ratings. Adient's ability to borrow against the ABL Credit Facility is limited to its borrowing base, which consists primarily of accounts receivable, inventory and certain cash account balances. Such working capital account balances fluctuate significantly depending on production levels and operating activities. Adient repaid $646 million of the outstanding ABL Credit Facility balance during the third quarter of fiscal 2020.

Adient also issued $600 million of senior secured notes due 2025 on April 20, 2020 to provide additional liquidity during the current COVID-19 pandemic. These notes will bear interest at 9% and will result in higher levels of net financing charges over the term of these notes. In addition, Adient's overall indebtedness has increased as a result of the issuance of these notes.

As a result of the impacts of the COVID-19 pandemic, Adient may be required to raise additional capital and its access to and cost of financing will depend on, among other things, global economic conditions, conditions in the global financing markets, the availability of sufficient amounts of financing, its prospects and credit ratings.

Adient may not be able to consummate the sale of YFAI and/or the sale of its fabrics business, or the time required to consummate the sale of YFAI and/or the sale of its fabrics business may be longer than anticipated.

Consummation of the sale of YFAI and the sale of its fabrics business are each subject to certain closing conditions, including expiration of waiting periods under anti-trust laws and other customary closing conditions. There can be no assurance that the closing conditions contained in the respective purchase agreements related to the sale of YFAI or the sale of the fabrics business will be satisfied or waived, or that the sale of YFAI and/or the sale of the fabrics business will be completed within the

Adient plc | Form 10-Q | 51

respective expected timeframes, on the respective proposed terms, or at all. In addition, the failure to consummate or a delay in consummating the sale of YFAI and/or the sale of its fabrics business would materially reduce Adient’s anticipated cash flow and could have a material adverse effect on the amounts available for general corporate or other purposes.

General economic, credit, capital market and political conditions could adversely affect Adient's financial performance, Adient's ability to grow or sustain its businesses and Adient's ability to access the capital markets.

Adient competes around the world in various geographic regions and product markets. Global economic conditions affect Adient's business. As discussed in greater detail below, any future financial distress in the industries and/or markets where Adient competes could negatively affect Adient's revenues and financial performance in future periods, result in future restructuring charges, and adversely impact Adient's ability to grow or sustain its businesses.

The capital and credit markets provide Adient with liquidity to operate and grow its business beyond the liquidity that operating cash flows provide. A worldwide economic downturn and/or disruption of the credit markets likely would reduce Adient's access to capital necessary for its operations and executing its strategic plan. If Adient's access to capital were to become constrained significantly, or if costs of capital increased significantly, due to lowered credit ratings, prevailing industry conditions, the volatility of the capital markets or other factors, Adient's financial condition, results of operations and cash flows likely would be adversely affected.

On June 23, 2016, the U.K. voted in a national referendum to withdraw from the European Union and in March 2017 the U.K. invoked Article 50 of the Treaty on European Union, which began the U.K.’s withdrawal from the European Union. The U.K. formally left the European Union on January 31, 2020 and entered into a transition period which is due to end on December 31, 2020, during which the U.K. and the European Union will seek to agree on the terms of their future relationship. Uncertainties in connection with the future of the U.K. and its relationship with the European Union have caused and may continue to cause disruptions to capital and currency markets worldwide. The consequences of a withdrawal by the U.K. from the European Union and the impact on markets, as well as the impact on Adient’s operations, remain highly uncertain, in particular, in respect of the U.K.’s future access to the European Single Market, its future regulatory environment and the free movement of capital and labor. This market volatility may lead to an increase in Adient’s cost of borrowing or the availability of credit, which may adversely impact Adient’s financial performance. The U.K.’s withdrawal from the European Union may also have a detrimental effect on Adient’s customers and suppliers, which would, in turn, adversely affect Adient’s revenues and financial condition. In

addition, the U.K.’s withdrawal from the European Union may also result in legal uncertainty and potentially divergent national laws and regulations as new legal relationships between the U.K. and the European Union are established.

Risks associated with joint venture partnerships may adversely affect Adient's business and financial results.

Adient has entered into several joint ventures worldwide and may enter into additional joint ventures in the future. Adient's joint venture partners may at any time have economic, business or legal interests or goals that are inconsistent with Adient's goals or with the goals of the joint venture. Adient may compete against its joint venture partners in certain of its markets and certain negotiations with its customers may negatively impact its joint venture business with those same customers. Disagreements with Adient's business partners may impede Adient's ability to maximize the benefits of its partnerships and/or may consume management time and other resources to negotiate. Adient's joint venture arrangements may require Adient, among other matters, to pay certain costs or to make certain capital investments or to seek its joint venture partner's consent to take certain actions. Adient does not control the ability to collect cash dividends from its non-consolidated joint ventures. Delays in the collection of dividends, even by a few days, could adversely affect Adient's financial position and cash flows. Adient's joint venture partners may be unable or unwilling to meet their economic or other obligations under the operative documents, and Adient may be required to either fulfill those obligations alone to ensure the ongoing success of a joint venture or to dissolve and liquidate a joint venture. Further, joint venture partnerships are subject to renewal or expiration at various times, specifically including the need to renew the YFAS joint venture by the end of 2022. Adient has recently entered into an agreement to extend the term of the YFAS joint venture until December 31, 2038, which transaction is subject to regulatory and other customary conditions of closing and is cross-conditioned on other transactions that Adient has entered into with Yanfeng related to the YFAI and AYM joint ventures. The failure to renew or extend the terms of Adient’s joint venture partnerships could impact other areas of Adient’s business, including its business relationships. The above risks, if realized, could result in an adverse effect on Adient's business and financial results.

Risks associated with Adient's non-U.S. operations could adversely affect Adient's business, financial condition and results of operations.

Adient has significant operations in a number of countries outside the U.S., some of which are located in emerging markets. Long-term economic uncertainty in some of the regions of the world in which Adient operates, such as Asia, South America

Adient plc | Form 10-Q | 52

and Europe and other emerging markets, could result in the disruption of markets and negatively affect cash flows from Adient's operations to cover its capital needs and debt service requirements.

In addition, as a result of Adient's global presence, a significant portion of its revenues and expenses is denominated in currencies other than the U.S. dollar. Adient is therefore subject to foreign currency risks and foreign exchange exposure. While Adient employs financial instruments to hedge some of its transactional foreign exchange exposure, these activities do not insulate Adient completely from those exposures. Exchange rates can be volatile and could adversely impact Adient's financial results and the comparability of results from period to period.

There are other risks that are inherent in Adient's non-U.S. operations, including the potential for changes in socioeconomic conditions, laws and regulations, including import, export, direct and indirect taxes, value-added taxes, labor and environmental laws, and monetary and fiscal policies; protectionist measures that may prohibit acquisitions or joint ventures, or impact trade volumes; unsettled political conditions; government-imposed plant or other operational shutdowns; backlash from foreign labor organizations related to Adient's restructuring actions; corruption; natural and man-made disasters, global health epidemics, hazards and losses; violence, civil and labor unrest; and possible terrorist attacks.

These and other factors may have an adverse effect on Adient's non-U.S. operations and therefore on Adient's business and results of operations.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds


(a) Unregistered Sale of Equity Securities

None.

(b) Use of Proceeds

Not applicable.

(c) Repurchase of Equity Securities

There has been no share repurchase activity during the three months ended June 30, 2020.

Item 3.

Defaults Upon Senior Securities


None.

Item 4.

Mine Safety Disclosures


Not applicable.

Item 5.

Other Information


None.

Adient plc | Form 10-Q | 53

Item 6.

Exhibit Index

EXHIBIT INDEX


Exhibit No.						Exhibit Title
10.1						Separation and Release of Claims Agreement by and among Adient US LLC and Cathleen A. Ebacher , dated May 31, 2020.

31.1						Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2						Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1						Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						XBRL Instance Document

101.SCH						XBRL Taxonomy Extension Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

Adient plc | Form 10-Q | 54

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


			Adient plc
			By:			/s/ Douglas G. Del Grosso
						Douglas G. Del Grosso
						President and Chief Executive Officer and a Director
			Date:			August 6, 2020

			By:			/s/ Jeffrey M. Stafeil
						Jeffrey M. Stafeil
						Executive Vice President and Chief Financial Officer
			Date:			August 6, 2020

Adient plc | Form 10-Q | 55

Adient (NYSE:ADNT)
Historical Stock Chart
From Mar 2024 to Apr 2024

Adient (NYSE:ADNT)
Historical Stock Chart
From Apr 2023 to Apr 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ADNT Adient plc

Latest ADNT Messages

Loading Messages....

Adient Plc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ADNT Adient plc

Latest ADNT Messages

Loading Messages....

Adient Plc News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App